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Abstract 
The United States health system strives to improve the care patients receive while 
reducing healthcare expenditures.  A significant portion of the nation’s healthcare expenditure is 
spent on end of life care.  Palliative care provides one solution to reducing healthcare 
expenditures while improving the patient experience.  Reducing symptom intensity is one 
example of palliative care’s success.  A midwest palliative care program was tasked to gather 
quality data on the service’s ability to manage patient symptoms. 
The program selected the MD Anderson Symptom Inventory to improve symptom 
assessment and provide quality metrics for the organization.  Additionally, research suggests 
rural populations have poorer access to palliative care services compared to non-rural patients.  
In response, a qualitative questionnaire was administered to rural and non-rural patients at 
consultation to gather information regarding barriers to palliative care services.  Finally, the 
quality improvement initiative was evaluated for acceptability, feasibility, and sustainability.   
The scholarly project provided the organization characteristics of the population served, 
accurately assessed symptoms, and tracked performance of symptom management over time. 
The implications of this project is the MD Anderson Symptom Inventory provided a sustainable 
and feasible plan for a community based palliative care program to generate and gather quality 
data.  The perceived barrier questionnaire revealed that patients experience symptoms for a long 
time prior to a palliative care referral and a knowledge gap exists regarding the role and 
existence of palliative care. 
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Executive Summary 
A midwest palliative care program was tasked to gather quality data on the service’s 
ability to manage patient symptoms.  Therefore, the MD Anderson Symptom Inventory 
(MDASI) was administered to new home-based palliative care referrals to improve symptom 
assessment and provide quality metrics for the organization.  Additionally, research suggests 
rural populations have poorer access to palliative care services compared to non-rural 
populations.  In response, a qualitative questionnaire was administered to rural and non-rural 
patients at consultation to gather information regarding barriers to palliative care services. 
Implementing the MDASI provided characteristics of the patient population’s symptoms 
at consultation.  The MDASI demonstrated that patients consulted for pain were in significant 
distress with an average pain rating of 7.93 out of 10 at consultation.  However, patients who 
were consulted for pain and had a follow up interaction in 1 week had a mean pain improvement 
score of 6.  The project design demonstrated that the MDASI is capable of measuring program 
effectiveness in managing symptoms over time.  Upon evaluation of the scholarly project, it was 
learned that implementing the MDASI at consultation, 1 week after consultation, and 1 month 
after consultation was acceptable, feasible, and sustainable for the organization. 
Immediately following the administration of the MDASI, 4 short answer questions were 
posed to patients during the consultation phone call.  The 4 questions were analyzed for themes 
and patterns.  Responses to the 4 short answer questions revealed that patients experience 
symptoms for long durations of time prior to receiving a palliative care referral. Additionally, 
patients reported a number of barriers to palliative care services.  The most frequently reported 
barrier was a lack of knowledge of the existence and role of palliative care.  In all, 17 of 25 
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patients did not receive palliative care sooner because of a knowledge gap.  Of these 17 patients, 
15 responded identically by saying, “I didn’t know about it.”  
Patients learned about palliative care most frequently from a primary care provider 
(PCP).  Specifically, 9 of the 25 patients learned about palliative care from a PCP.  An analysis 
of co-occurrences deduced that 4 of the 5 patients that reported symptom duration in years 
learned about palliative care from a PCP.  Oncologists were the second most frequent source of 
palliative care knowledge, educating 4 patients.  Lastly, all patients responded, “no” when asked, 
“Do you believe where you live impacted your ability to receive palliative care?” 
The qualitative analysis of patient perceived barriers to palliative care is consistent with 
the concerns already described in literature.  Patients in both rural and non-rural communities 
suffer from unrelieved symptoms for long durations of time prior to receiving palliative care.  
The qualitative analysis was also consistent with literature that suggests a knowledge gap in rural 
and non-rural communities.  Although this knowledge is not new, it validates the need for 
improved widespread education of palliative care’s existence and role. 
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Acceptability of the MD Anderson Symptom Inventory and qualitative analysis of barriers to 
palliative care services for rural and non-rural populations 
The goal of current healthcare reform known as the triple aim is to improve the health of 
populations, reduce cost, and improve the patient experience through quality care and improved 
patient satisfaction (Berwick, Nolan, & Whittington, 2008).  The United States spends more 
money on healthcare than any other country yet our health outcomes are inferior to most 
developed countries (Bharadwaj et al., 2016).  Moreover, in the United States there is a 
significant disparity in the allocation of healthcare resources among the population.  In fact, in 
the United States two thirds of the nation’s healthcare expenditures are spent on just 5-10% of 
the population.  This disproportionate utilization of limited healthcare resources is largely 
accrued during end of life.  Although only 5% of patients with Medicare die each year, end of 
life care accounts for roughly 25% of Medicare expenditures (Riley & Lubitz, 2010). 
Background and Significance 
Almost one quarter of seniors live with at least 4 chronic medical conditions (Chen et al., 
2015).  The final stage of life in patients with chronic conditions is often characterized by heavy 
and aggressive healthcare utilization.  However, research demonstrates that aggressive medical 
interventions in the final weeks of a patient’s life such as emergency department visits, 
hospitalizations, intensive care unit admissions, and chemotherapy administration are all 
associated with poor quality of life, poor quality of death, and perceived poor quality of end of 
life care by caregivers (Higgins, Garrido, & Prigerson, 2015; Hui et al., 2014).  Palliative care 
can address this issue by providing guidance to patients and families to choose appropriate 
therapies that coincide with a patient’s goals and wishes.  
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Palliative care is an interprofessional discipline that focuses on quality of life for patients 
with a life limiting illness by managing symptoms, facilitating communication, and guiding 
patients through medical decision-making (Hui et al., 2014).  Quality palliative care is associated 
with reduced symptom burden, improved quality of life, increased patient and family 
satisfaction, cost avoidance, and reduced hospitalizations (Kerr, Tangeman, et al., 2014).  
Hospital systems have adopted palliative care programs in order to improve quality indicators 
and reduce costs.  More recently, new recommendations encourage hospital systems to build and 
implement community based palliative care programs as an effort to involve palliative care 
earlier in a patient’s experience with a life limiting illness (Kerr, Tangeman, et al., 2014). Earlier 
palliative care engagement guides proactive rather than reactive decision-making, assessment 
and treatment of distressing symptoms sooner, and improves quality of life.  In fact, an outpatient 
palliative care referral has been observed as an independent factor for improved end of life care 
(Hui et al., 2014).   
Problem Statement 
According to a comprehensive organizational assessment, a midwest community based 
hospice and palliative care program had a strong desire to gather metrics of program 
performance in order to evaluate the organization’s progress towards achieving the mission and 
vision.  The purpose of this project was to implement and evaluate an evidence-based symptom 
inventory tool in a community based palliative care program.  
Community based palliative care teams are known to reduce cost and improve quality of 
life by managing distressing symptoms (Brumley et al., 2007).  These services however are 
unavailable to many rural communities (M. A. Bakitas et al., 2015).  In this project, the patient 
population was divided between rural and non-rural areas.  To investigate this concern, 
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additional focused assessment on the differences between rural and non-rural palliative care 
patients was completed to procure insights regarding perceived barriers to accessing palliative 
care services. 
The Theory of Distressing Symptoms was used as a theoretical framework to guide the 
selection and implementation of the symptom inventory tool.  Short answer questions were 
formulated to inquire about patient knowledge of palliative care services, establish the duration 
of time the patient experienced symptoms prior to referral, determine perceived barriers to 
accessing services, and perceptions of how demographics may impact access to services.  
Finally, the organization’s acceptance of the implementation was measured through staff 
questionnaires.  
The evidence for the chosen tool and a plan for implementation and evaluation was 
outlined and discussed.  The Theory of Unpleasant Symptoms guided conceptualization of the 
symptom experience and the PARiHS model directed implementation of the quality 
improvement project.  Finally, the project describes stakeholder support, presents a plan for 
project sustainability, examines the results and implications for practice, and outlines how 
outcomes will be disseminated.  The examination of literature begins with a discussion of the 
Symptom Science movement because of Symptom Science’s mission to expand symptom 
knowledge. 
Symptom Science 
 The Symptom Science Model was created by the National Institute of Nursing Research 
to direct biobehavioral research, improve symptom management, and study tissue injury (Henly, 
2015).  The Symptom Science Model guides the description of complex symptoms, phenotypic 
characterization, and biomarker discovery for clinical application.  The goal of this model is to 
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expand the understanding of symptoms and symptom management to improve outcomes and 
health-related quality of life (Cashion & Grady, 2015).  The Symptom Science Model was 
created to make symptom research meaningful.  Symptom Science researchers hope to further 
understand symptom clusters and the trajectory of distressing symptoms over time by forming 
interdisciplinary teams and encouraging cohesive methodology (Dodd et al., 2001).   
 Symptom assessment and symptom management is central to the role of nursing (Corwin 
et al., 2014).  Nurses are well educated and are in an ideal position to analyze symptom triggers, 
reduce severity, and improve the symptom experience.  However, the field of symptom science 
faces many challenges (Henly, 2015).  Symptom research is challenging because it is difficult to 
generalize and compare across populations and research studies (Dodd et al., 2001).  Moreover, 
literature on symptom management utilizes up to 47 different symptom measurement tools 
(Paice, 2004).  The array of tools often measure different symptom clusters and use a variety of 
different scaling techniques.  After addressing the problem of gathering quality and cohesive 
data, the final challenge identified by the Symptom Science researchers is knowledge 
dissemination.  It is essential to expand understanding of the symptom experience to improve the 
care offered to suffering populations. 
Symptom impact on health 
 Unrelieved symptoms significantly impact a patient’s quality of life and ability to 
function (Cleeland et al., 2000).  Unpleasant symptoms profoundly alters and limits activities, 
negatively impacts family relationships, impairs work productivity, and decreases quality of life 
(Dodd et al., 2001).  Symptoms can also lead to the feeling of sadness, fear, vulnerability, and 
cause profound distress (Carlson, Waller, & Mitchell, 2012).  For example, researchers suggest 
that unrelenting pain can lead to depression, anxiety, panic, social isolation, and spiritual crisis.  
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Unpleasant symptoms contribute to distress and are a major detriment to quality of life and 
functional ability (Cleeland et al., 2000). 
A large symptom burden leads to poor quality of life in patients with a life-limiting 
illness.  In 2016, there were approximately 14.5 million Americans fighting cancer (National 
Cancer Institute, 2016).  Symptomology literature over the last decade consistently reports a high 
prevalence of symptoms in cancer patients in tertiary care, hospice, and community settings (V. 
T. Chang, Hwang, Feuerman, & Kasimis, 2000).  Patients undergoing cancer treatment are 
known to report an average of 11 to 13 concurrent symptoms (Fan, Filipczak, & Chow, 2007).  
Researchers conducting a study in a Veterans Affairs hospital also reported a complex symptom 
experience, describing a median of 8 concurrent symptoms among cancer patients (V. T. Chang 
et al., 2000).  The most consistent symptoms reported and identified were pain, fatigue, dry 
mouth, shortness of breath, and difficulty sleeping.  Moreover, in these studies pain was never a 
solitary symptom.  In fact, patients experiencing intense fatigue and pain were most likely to 
experience a multitude of other symptoms as well.  Pain and fatigue were closely tied to the 
symptoms of dry mouth, dyspnea, fatigue, and weight loss (V. T. Chang et al., 2000). 
Cancer and heart failure are the 2 most frequently represented diseases within the field of 
palliative care.  Over 5 million Americans are diagnosed with chronic heart failure with a yearly 
incidence of at least 500,000 (Go et al., 2014).  Like cancer, persons with end stage heart failure 
also have a high symptom burden (Adler, Goldfinger, Kalman, Park, & Meier, 2009).  Patients 
with heart failure endure a mean of 9 symptoms concurrently.  The most common symptom 
clusters noted in heart failure research are shortness of breath, fatigue, pain, drowsiness, and dry 
mouth (Bekelman et al., 2007).  Heart failure may also lead to significant psychological, 
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physical, and economic burden.  Thus there is a tremendous need for community based palliative 
care to relieve suffering and improve quality of life in this population. 
Community Based Palliative Care Programs 
Distressing symptoms are the most common reason patients seek healthcare (Xiao, 2010).  
Palliative care services significantly reduce unpleasant symptoms in patients with a life limiting 
illness (Bharadwaj et al., 2016).  The initiation of palliative care within 48 hours of a hospital 
admission has been shown to decrease hospital length of stay by roughly 5 days, reduce overall 
hospital costs by as much as 40%, and has an insignificant impact on mortality rates.  According 
to Bharadwaj et al. (2016) readmission rates are also significantly reduced at 30, 60, and 90 days 
following hospital discharge if palliative care is consulted early in a hospital stay.  In addition, 
patients may require a hospital readmission and undergo unnecessary suffering (Chen et al., 
2015).  Hospital readmissions cause further distress and life interruption for both patients and 
caregivers. 
Hospital readmissions are traumatizing to patients and are expensive and burdensome for 
the healthcare system.  Financial penalties continue to climb for institutions with high 
readmission rates to provide incentives to improve care and reduce readmissions (Kripalani, 
Theobald, Anctil, & Vasilevskis, 2014).  Moreover, readmissions cost the United States 
healthcare system 17.4 billion dollars annually in Medicare expenditures alone.  Over one 
quarter of patients readmitted within 30 days of discharge are patients with heart failure.  To 
address this issue research attempted to determine which interventions could reduce hospital 
readmissions for high-risk patients.  Timely follow-up, medication reconciliation, patient 
education, home visits, and patient centered discharge instructions are interventions that 
significantly reduced hospital readmissions.  All of these interventions improve the patient 
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experience and are at the core of community based palliative care services (Kerr, Tangeman, et 
al., 2014). 
 Outpatient palliative care services reduce hospitalizations and increase hospice 
utilization, which further reduces healthcare costs and improves quality care at the end of life 
(Blackhall et al., 2016).  Kerr et al. (2014) found that an outpatient palliative care referral 
increased hospice admission by 45% as compared to a control group and increased the duration 
of hospice services by 25 days.  In the same study, patients with an outpatient palliative care 
referral utilized fewer healthcare resources and saved an average of 11,724 dollars in the last 3 
months of life.  The cost of care for the treatment group in the final week of life was half of that 
for the control group.  Increased hospice utilization is important for cost avoidance but it is also 
important for quality care (Higgins et al., 2015).  Hospice focuses on preventing and relieving 
symptoms and prepares family and patient for the time near death (Lynn, 2001).  According to 
Higgins et al. (2015) the duration of hospice care and location of death are the most significant 
factors for patient caregiver’s perceived quality of end of life care.  Hospice admissions within a 
week of a patient’s death is associated with poor caregiver perceived quality of end of life care 
and can often be avoided with early outpatient palliative care involvement. 
A primary objective of palliative care is the discussion, documentation, and fulfillment of 
advanced directives.  In fact, patients receiving community based palliative care are 3 times more 
likely to complete advanced directives (Chen et al., 2015).  Although hospice benefits have been 
a Medicare approved service for over 3 decades, hospice continues to be underutilized or 
initiated too late (Brumley et al., 2007).  In 2007, 60% of deaths occurred in the hospital despite 
the fact that most patients wish to die at home (Brumley et al., 2007).  In one study, improved 
advanced care planning with community based palliative care resulted in a reduction of hospital 
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admissions by 59% and shorter lengths of stay by over 5 days per patient (Chen et al., 2015).  
One hospital implemented an automatic palliative care referral system that triggered referrals for 
patients that were admitted with a life limiting illness.  The hospital found that the automatic 
referral system significantly reduced aggressive end of life treatment and improved patient 
satisfaction (Maltoni et al., 2016).  This research is consistent with other literature that 
demonstrates reduced aggressive end of life treatment improves perceived quality of end of life 
care (Higgins et al., 2015; Maltoni et al., 2016).  Community based palliative care increases 
patient satisfaction, increases likelihood of dying at home, reduces overall cost of care, and 
promotes the fulfillment of healthcare end of life wishes (Brumley et al., 2007).  
 Oncology patients are the largest population of patients that utilize palliative care 
services.  As cancer treatment has improved over time, the perception of cancer has changed: 
more recently cancer has become viewed as a chronic illness that is predominantly managed in 
the ambulatory setting.  Therefore, the most ideal setting to provide palliative care for oncology 
patients is in the outpatient setting (Hui et al., 2014). 
It is valuable to note that symptom burden, in both number and severity of symptoms is 
not related to the extent of one’s disease (V. T. Chang et al., 2000).  Therefore, patients with less 
advanced cancer in the outpatient setting may suffer from a similar symptom burden as those 
hospitalized for an advanced disease.  Oncology patients in the outpatient setting may experience 
a multitude of symptoms that can be quickly resolved by palliative care engagement. 
The impact of palliative care can be measured and identified quickly following a 
consultation.  In one study, outpatient palliative care improved the patient’s symptom experience 
within the first week of a palliative care consultation (Follwell et al., 2009).  Palliative care 
services provided a 10% symptom reduction compared to baseline within the first week of 
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palliative care initiation.  With continued palliative care involvement these results were sustained 
at 1 month.  Patient satisfaction was significantly higher in the palliative care treatment group 
compared to the control group at 1 week and 1 month after the palliative care consultation. 
Symptom reduction is important for quality of life but it may also be important to 
continue with treatment.  Peripheral neuropathy, fatigue, intractable pain, and intractable nausea 
are all symptoms that can delay, halt, or result in dose reductions of chemotherapy or radiation.  
Changing treatment course may be necessary but can impact effectiveness of therapy, which can 
be fatal (J. Chang, 2000).  Improving distressing symptoms that result in treatment delay or dose 
reduction is imperative to proceed with preferred treatment regimens. 
Although, cancer and its treatment are distressing, palliative care can help reduce 
treatment distress.  Rummans et. al (2006) studied quality of life in a cohort of patients 
undergoing radiation therapy for cancer.  Quality of life was measured prior to and following 
radiation for a control group and a multidisciplinary treatment group.  The multidisciplinary 
group included palliative care services.  During the study, the control group had significantly 
poorer quality of life scores after radiation compared to baseline scores.  After radiation, the 
multidisciplinary treatment group showed improved quality of life scores compared to the 
control group and compared to baseline (Rummans et al., 2006).  This evidence suggests that 
quality of life can be sustained or even improved while undergoing cancer treatment with the 
involvement of a palliative care team and a multidisciplinary treatment approach.  Palliative care 
services improve quality of life and should be available to all populations (M. Bakitas et al., 
2009; Brumley et al., 2007; Hui et al., 2014). 
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Rural Populations 
Rural areas are home to roughly 70 million Americans accounting for 23% of the United 
States population (Befort, Nazir, & Perri, 2012).  Evidence suggests there is a disparity between 
rural and non-rural populations in referral and access to palliative care services (M. A. Bakitas et 
al., 2015).  Patients residing in the rural setting have different demographics, perspectives on 
health, and social structures than those in urban settings.  Rural populations are more likely to be 
older, less educated, poor, and diagnosed with cancer at a later stage (Hughes, Ingleton, Noble, 
& Clark, 2004).  According to Hughes et al. (2004) rural patients typically have a different 
perspective on health and wellbeing.  These patients are more likely to view health as the 
capability of being self-reliant with the ability to work.  The culture of rural populations 
combined with poor access to healthcare services impacts the way rural populations view 
disease, life, and death. 
Rural areas frequently have limited healthcare resources (M. A. Bakitas et al., 2015).  
Many rural hospitals lack palliative care programs and have little to no community-based 
services.  Patients with cancer and other life limiting illnesses in rural areas may be unaware of 
services such as palliative care and may not have access to education regarding palliative care 
services.  Evidence suggests that palliative care services are equally effective in reducing health 
care costs and promoting quality of life in rural areas as urban (M. A. Bakitas et al., 2015).  Yet 
rural communities continue to be underserved. 
Simply reproducing urban palliative care models may not translate into the rural setting.  
Researchers believe that palliative care implementation in rural areas may require unique 
implementation and practice models due to the unique challenges facing these programs.  Rural 
community based palliative care programs often have scarce resources, a shortage of certified 
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palliative care practitioners, and small patient volumes (Ceronsky, Shearer, Weng, Hopkins, & 
McKinley, 2013).  Additionally, researchers describe a knowledge gap regarding palliative care 
services in patients, providers, and communities (Hughes et al., 2004).  Large stakeholder 
investment from rural communities and health settings will be essential to develop and 
implement new rural specific palliative care models in order for community based palliative care 
to become a reality in rural communities. 
The caregiver structure is often different within rural populations as well (Hughes et al., 
2004).  Rural patients are more likely to receive care from a spouse because rural populations are 
more likely to be married than non-rural populations (Glasgow, 2000).  Among informal 
caregivers, children are next in importance in providing care for parents.  Although rural 
populations produce more children than non-rural it appears rural populations have less physical 
access to those children.  Rural populations have less access to offspring and other young people 
because of the increased geographic mobility among young populations (Glasgow, 2000).  
Because of this phenomenon older people living in rural communities are more likely to receive 
non-kin assistance from other elders than older people in urban communities.  Overall, older 
rural residents have stronger informal social support networks and receive more informal 
caregiving than urban populations.  The differences in social structure and caregiving are 
important to identify when studying rural populations and potential barriers to accessing 
palliative care. 
Common themes were discovered during the literature review of rural patients’ access to 
palliative care services.  Researchers report that patients residing in rural areas have less access 
to palliative care services than those residing in urban settings (M. A. Bakitas et al., 2015).  Rural 
patients are referred to palliative care later than urban patients and spend more time with 
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unrelieved symptoms prior to attaining services.  Ceronsky et al. (2013) and Hughes et al. (2004) 
have proposed that rural patients do not receive palliative care services in a timely manner due to 
scarce rural resources, lack of palliative care models specific for rural communities, lack of 
certified rural palliative care practitioners, poor sustainability of programs due to small patient 
volumes, and because of a knowledge gap of palliative care services in patients and 
communities.  External barriers have been studied but little literature exists on patient perceived 
barriers to palliative care.  It would be advantageous to learn how patients in the region of 
interest are learning about palliative care services, determine perceived barriers to services, and 
if patients believe region of residence influences access to palliative care.  The community based 
palliative care team is missioned to improve the quality of life of patients with a life limiting 
illness in the region.  The knowledge gap that exists in the region and nation is limiting palliative 
care from reaching patients who would benefit from thorough symptom assessment and effective 
treatment regimens.  However, the symptom experience is complex and challenging to measure 
(Henly, 2015). 
Measuring Symptoms 
The study and description of complex symptoms and symptom clusters has long been a 
focus of nursing science (Henly, 2015).  Despite current technological advances in symptom 
management, little has been done to improve symptom measurement (Dodd et al., 2001).  A gold 
standard to measure the patient symptom experience does not exist.  So as a result, measuring the 
subjective symptom experience is challenging, and continuing to seek an accurate and thorough 
symptom assessment is crucial to provide high quality care.  Inconsistent and inadequate 
symptom assessments lead to unrelieved symptoms, which decreases quality of life and impairs 
physical function (Cleeland et al., 2000).  Symptoms impact functional capacity and also can 
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interrupt treatment if severe enough.  Thus, symptoms must be assessed accurately and 
frequently.  
Symptom researchers believe that many symptoms are not adequately identified or 
treated (Cleeland et al., 2000).  Due to the subjective nature of distressing symptoms many 
providers under appreciate patient’s symptom burdens.  Some assert that oncologists and 
healthcare professionals do not proactively assess symptoms and wait until symptoms are 
spontaneously reported (Kerr, Tangeman, et al., 2014).  Many providers believe that patients will 
voluntarily report symptoms if they are truly distressing.  However, patients often hesitate to 
report symptoms until severe and require emergency department evaluation or hospitalization 
(Kerr, Donohue, et al., 2014).  Patients also under report symptoms because they want to be a 
“good” patient, are resistant to taking additional medications, or have difficulty admitting the 
disease may be progressing.  Many patients do not want to bother providers and family members.  
Chang et al. (2000) claims patients may assume the provider already knows when the patient 
experiences symptoms and that reporting is unnecessary.  These significant barriers underline the 
importance of a comprehensive symptom assessment tool and consistent follow up by providers 
(V. T. Chang et al., 2000). 
Measuring What Matters 
The American Academy of Hospice and Palliative Medicine and the Hospice and 
Palliative Nurses Association recently began a project to identify the most important quality 
measures in palliative care and hospice (Dy et al., 2015).  With the goal to improve quality of life 
for patients undergoing treatment for a serious illness, the Measuring What Matters (MWM) 
project selected a set of measures proven to impact quality of care.  The MWM team comprised 
of nurses and physicians and was able to identify 75 published measures relevant to hospice and 
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palliative care.  The MWM project achieved consensus on 10 recommended measures which 
included: 1) comprehensive assessment; 2) screening for shortness of breath and development of 
a management plan; 3) screening for pain and providing treatment within 24 hours; 4) screening 
for nausea and constipation during initial consultation; 5) documentation of a discussion 
regarding psychological and emotional needs; 6) documentation of a discussion of spiritual needs 
and concerns; 7) completing documentation of surrogate decision makers; 8) documentation of a 
discussion regarding preferences for life sustaining treatments;  9) completion of the necessary 
documentation regarding end of life preferences for vulnerable elders; and 10) surveying patient 
and family satisfaction.  The MWM project created a foundation to evaluate hospice and 
palliative care programs and established standards to promote program accountability.  
Assessment tools assist programs in measuring what is important.  In the next sections a variety 
of measurement tools are discussed. 
Assessment Tools 
A good symptom inventory is important to improve early symptom detection and 
treatment.  Providers need a tool that can identify symptoms, determine severity, and that is 
sensitive enough to detect a response to treatment or changes in health (Cleeland et al., 2000).  In 
conducting a systematic review of instruments, Paice et al. (2004) found 47 pain, symptom, and 
palliative care tools but reported that none were ideal.  Creating a perfect symptom assessment 
tool is challenging due to the complexity and variety of symptoms a patient may experience.  
Making matters more challenging, symptom experiences are specific to the disease and 
individual.  What may be an ideal symptom assessment tool for one palliative care patient may 
not be applicable to another.  In the next sections, several common symptom inventories are 
discussed with their relative benefits and limitations. 
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Palliative Outcome Scale 
 The POS was developed to measure palliative care outcomes as a whole rather than by 
symptom management.  The goal of the POS is to create higher standards of care by determining 
if patient and family needs are being addressed effectively and efficiently (Hearn & Higginson, 
1999).  According to the creators of the POS, it provides an efficient measurement tool designed 
to meet the need for a short and easy assessment of palliative care core quality measures.  The 
POS consists of 10 Likert scale questions and 2 short answer opportunities.  The symptoms 
measured include pain, nausea, coughing, constipation, anxiety, and psychosocial components.  
In addition to symptom measures, the POS poses questions regarding goals of care discussions 
and whether the patient feels needs are being addressed.  The POS is validated and reliable for 
hospice and palliative care in the inpatient and outpatient setting (Hearn & Higginson, 1999). 
The POS is the most well rounded palliative outcome scale that meets most of the MWM 
project points of focus.  This assessment may be helpful in evaluating patient care but is not 
applicable at consultation.  The scale takes roughly 8 minutes to complete but may require 
frequent clarification.  Additional concerns regarding the POS are the questionable 
responsiveness to treatment and the low Cronbach’s alpha score of 0.65 suggesting poor internal 
consistency (Paice, 2004).  The POS measures a program’s overall performance but is less 
effective in measuring a program’s ability to manage patients’ symptoms. 
M.D. Anderson Symptom Inventory 
The MD Anderson Symptom Inventory (MDASI) was created specifically for the 
oncology population.  The MDASI measures the severity of 13 symptoms and 6 interference 
items on an 11-point scale (Cleeland et al., 2000).  The tool measures pain, fatigue, nausea, 
disturbed sleep, distress, shortness of breath, remembering, appetite, drowsiness, dry mouth, 
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sadness, vomiting, and numbness or tingling.  The interference items ask the patient how much 
the symptoms interfere with the patient’s general activity, mood, ability to work around the 
house, relationships, walking, and enjoyment of life.  The average completion time of the 
questionnaire is 5 minutes.  The MDASI was created and validated to be administered over the 
phone or via interactive voice response.  The tool is also psychometrically validated in 7 
different languages.  The test-retest coefficient for the MDASI is 0.75-0.96 and has been 
validated within the cancer population with a Cronbach’s alpha of 0.85 to measure symptoms 
and 0.93 in the interference items (Paice, 2004).  
The MDASI has been validated time and time again with a variety of cancer diagnoses 
(Cleeland et al., 2000) but the MDASI has not been specifically validated within the broad and 
expanding palliative care field.  However, the symptom clusters of the MDASI are similar to 
those in the Edmonton Symptom Assessment Scale (ESAS) and other validated palliative care 
assessment tools (Paice, 2004).  Additionally, the MDASI has a large operational and 
implementation advantage in that it can be administered and validated over the phone or through 
automated interactive voice response (Cleeland et al., 2000).  
Cancer treatment guidelines recommend the regular assessment of the influence of pain 
on activities such as work, sleep, and social interactions (Cleeland et al., 2000).  The interference 
items on the MDASI meet this guideline and were a significant contributor to the selection of the 
MDASI for implementation.  The midwest palliative care team chose the MDASI as the 
symptom inventory of choice for this implementation project because of the ability of the tool to 
measure symptom clusters, the addition of the interference items, and the validation of 
administration over the phone. 
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Frequency of Administration 
To determine frequency of MDASI administration for the project design a brief literature 
review was conducted.  Upon review, there are no explicit recommendations for reassessment of 
symptoms in palliative care follow-up.  There are however general guidelines for a variety of 
different patient populations.  The Center for Disease Control and Prevention (CDC) 
recommends monitoring patients receiving chronic opioid therapy every 3 months (Dowell D, 
Haegerich TM, & Chou R, 2016).  High-risk non-cancer patients receiving chronic opioid 
therapy should receive follow-up as often as weekly (Chou et al., 2009).  All patients with cancer 
should be screened for pain and distressing symptoms at each point of contact (Ripamonti, 
Santini, Maranzano, Berti, & Roila, 2012).  Measuring and identifying pain regularly is essential 
to effectively manage cancer pain.  The exact symptom assessment intervals however, depend on 
severity of symptoms and patient setting (Walsh et al., 2008).  Patients residing in the outpatient 
setting may require follow up by phone.  Specific follow up recommendations do not exist for 
this population.  However, theories are available to guide conceptualization of unpleasant 
symptoms to deepen the understanding of this phenomenon. 
Theory of Unpleasant Symptoms 
The Theory of Unpleasant Symptoms (TOUS) is a middle ranged theory intended for 
application by nurses and clinical researchers (Peterson & Bredow, 2009).  The TOUS was the 
first symptom theory to describe multiple symptoms occurring simultaneously and to depict an 
interaction between them.  The TOUS asserts that symptoms potentiate and catalyze one another 
and the treatment of one symptom will contribute to the management of another.  The TOUS is a 
theoretical framework used to guide studies of patient’s symptom experience.  The framework 
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has been used to study symptoms associated with a variety of illnesses including cancers, chronic 
obstructive pulmonary disease, heart failure, transplant surgeries, and the postpartum period. 
The Theory of Unpleasant Symptoms depicts antecedent factors, the symptoms 
themselves, and symptoms’ impact on performance.  In the TOUS, symptoms do not occur in a 
vacuum.  The authors are aware that a patient’s situation, environment, demographics, psyche, 
and physiology all impact the symptom experience.  These influencing factors or antecedent 
factors are conceptualized into 3 categories: physiological factors, psychological factors, and 
situational factors.  Each symptom is measured in multiple dimensions. The dimensions 
measured include duration, intensity, distress, and quality.  The framework illustrates the 
interaction of symptoms in a stacked configuration.  The final concept in the TOUS is 
performance.  Lenz et al. (1997) asserts that symptoms affect performance and in turn 
performance influences symptoms and the antecedent factors.  Appendix A presents a depiction 
of the theory’s conceptual model.   
The TOUS can be applied to rural populations.  Rural populations have different social 
and physical environments (M. A. Bakitas et al., 2015).  Rural populations also have different 
physiological characteristics.  Specifically, rural populations are more likely to be diagnosed at 
an advanced stage of disease, more likely to be older, and often have different perceptions of 
health and illness (Hughes et al., 2004).  Rural populations may also have unique antecedent 
factors and, according to the TOUS, different factors impact the symptom experience.  The 
formation of questions posed to rural populations is guided by the antecedent factors depicted in 
the TOUS. 
The MDASI was created to measure common symptom clusters that occur concurrently 
(Cleeland et al., 2000).  Cleeland et al. (2000) asserts that multiple symptoms have a cumulative 
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 26	
effect on one another and on performance.  Consistent with the TOUS, this author also 
emphasizes the importance of assessing multiple symptoms simultaneously to reduce patient 
distress.  The symptom inventory assesses multiple symptoms on a 0-10 scale to assess intensity.  
The MDASI also assesses distress and performance through the interference items.  However, 
the MDASI does not measure duration or quality of symptoms.   
In summary, the MDASI is consistent with the concepts in the TOUS and serves as a 
sound measurement tool to measure multiple concurrent symptoms and the impact of symptoms 
on performance.  A middle range theory has guided conceptualization of this project, a literature 
review was conducted to understand barriers to symptom assessment in those with life limiting 
illness, and the MDASI has been chosen to measure symptoms.  The implementation model 
utilized to guide and support the implementation process will be discussed next.  
PARiHS Implementation Model 
 The Promoting Action on Research Implementation in Health Services (PARiHS) 
implementation framework is a useful and practical guide for the implementation of evidence 
based practice (Rycroft-Malone, 2004).  The PARiHS framework was created within the Royal 
College of Nursing Institute in the United Kingdom as an attempt to portray the complexity of 
change processes when implementing research based evidence into practice.  The key factors 
within the PARiHS framework are evidence, context, and facilitation (Rycroft-Malone, 2004).  
Each factor in the framework is on a high or low continuum.  Using the PARiHS framework and 
a variety of implementation attempts, Rycroft-Malone et al. (2004) assert that in order for 
implementation to be successful there must be clarity regarding the nature of evidence, a quality 
context, and skilled internal and external facilitation.  The most successful implementations 
occur when scientific support is strong, the implementation contributes to patient satisfaction, 
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and when the professional team agrees on implementation strategies.  Other factors consistent 
with successful implementation include strong leadership, a context receptive to change, and the 
presence of feedback systems with accountability. 
Evidence 
 Evidence is “knowledge derived from a variety of sources that has been subjected to 
testing and has been found to be credible” (Rycroft-Malone, 2004, p. 311).  Within the PARiHS 
framework evidence is not merely research driven, evidence also entails clinical and patient 
experience.  There is considerable evidence of the importance of a consistent assessment of 
symptoms using a standard and validated measure within the palliative care population (Paiva et 
al., 2014).  In existing research, consistent symptom assessment has a significant impact on 
patient experience and quality indicators (Paiva et al., 2014).  The providers at the midwest 
palliative care program were aware of the importance of frequent and consistent symptom 
measurement; however, the previous clinical experience with administering instruments and 
gathering quality measures had been inconsistent.  The providers had a negative clinical 
experience with measurements; viewing previous implementations as cumbersome and 
interruptive.   
In summary, the evidence for the implementation project was high.  The literature review 
was also consistent on the impact of frequent symptom assessment using a standard 
measurement tool on quality of care and on the patient experience (Paiva et al., 2014).  However, 
the personal clinical experience of evidence was low.  Overall, the evidence for the 
implementation project was moderate to high. 
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Context 
 Context refers to the environment in which the implementation is taking place.  
Contextual factors include the organization’s culture, leadership, and evaluation.  The midwest 
hospice and palliative care organization had a culture that was accepting of change especially 
when change might lead to actualization of the organization’s vision.  The organization 
underwent radical changes over the previous 5 years, increased patient census, and became 
fiscally sustainable as a result.  The organization experienced and survived this change because 
of strong leadership.  The leadership was supportive of the implementation process and was 
willing to contribute the necessary resources to sustain the project following the doctoral 
student’s involvement.  Evaluation was achieved both internally and externally.  Internal 
evaluation occurred as the symptom inventory established a measure for provider effectiveness.  
The implementation of the MDASI allowed the organization to track symptoms and determine 
the effectiveness of symptom treatment regimens.  Additionally, providers and organizational 
leadership evaluated provider based effectiveness in order to identify areas of opportunity for 
education.  External evaluations included invested community stakeholders and may support 
government accountability in the future.  The organization desired quality measures to present to 
donors, invested community stakeholders, and third party payers.  The context of implementation 
in the palliative care program was high due to the positive culture of change, strong leadership, 
and internal and external evaluation. 
Facilitation  
 Facilitation is a technique in which a person guides implementation and makes the 
implementation process easier for others.  The facilitator’s knowledge and skills play a key role 
in impacting the context.  The facilitator’s role is to help and support implementation by 
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providing advice, coordinating efforts between members of the healthcare team, and encouraging 
others to think critically to assess the achievement of goals.  In this quality improvement project 
the doctoral student was the facilitator of the implementation of the project.  The key functions 
of the facilitator role was to be the expert on the topic, to design evidence-based processes, to 
guide implementation, to evaluate effectiveness of implementation, and to impress the 
importance of continuing the project following student involvement.  Thus there was significant 
investment of the facilitator for implementation of the project, and there was motivation for the 
facilitator to achieve the unified objectives. 
Organizational Assessment 
Organizational change is a type of chaos (Gleick, 1988).  Systems alone are complex but 
change becomes even more complicated when humans are involved (Burke & Litwin, 1992).  
However, consistent patterns exist to draw conclusions, make predictions, and guide change 
within human systems.  The Burke-Litwin Model was created through sound theory and research 
to evaluate organizations considering large changes.  This model attempts to portray primary 
variables and the connecting linkages that should be considered when undergoing organizational 
change. 
The Burke-Litwin Model of Organizational Change was used to guide research and 
interviews with members of the midwest palliative care program.  The Burke-Litwin model 
predicts organizational performance and its capacity for change (Armenakis & Bedeian, 1999).  
This model focuses on organizational conditions and how elements of change impact different 
organizational variables.  Appendix C depicts the model and shows the relationship between 12 
organizational variables.  Variables in the Burke-Litwin model include: external environment; 
mission and strategy; leadership; organizational culture; structure; management practices; 
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systems (policies and procedures); work unit climate; task and independent skills; motivation; 
individual needs and values; and individual and organizational performance.  The relationships 
depicted in the model are either transformational or transactional.  Transformational change most 
often occurs though interactions with environment forces.  Transformational change requires 
behavioral and cultural change of the individuals and of the organization as a whole.  
Transactional change occurs through short-term interactions between people and groups and 
often includes an exchange of information or services.   
Burke-Litwin Assessment 
The Burke-Litwin Model of Organizational Change was selected to assess the midwest 
hospice and palliative care team due to the model’s ability to assess organizational performance, 
need for change, and capacity for change.  The organization previously attempted to implement 
symptom inventory quality measures without success.  The Burke-Litwin model was used to 
understand why previous implementation failed and how the organization managed change.  The 
organizational assessment was completed through interviews with the Executive Director, 
Director of Business Development, Director of Quality and Education, Registered Nurse, and the 
Medical Director.  The assessment of the organization begins by studying the external 
environment. 
External Environment 
According to Burke and Litwin (1992) the external environment is the most pivotal factor 
of organizational change.  The external environment is the conditions and situations outside the 
organization’s walls that impact function, vision, and performance.  In the region alone there 
were 16 organizations that provided palliative and hospice care.  According to the director of 
business, the palliative care and hospice field became dense and competitive in the geographical 
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area with non-profit organizations and for-profit organizations fighting for patients.  At times the 
competition was not friendly.  The organization could not be sustained without an adequate 
census of patients.  Therefore, the intense competition impacted marketing strategies and overall 
functioning of the organization. 
According to the Director of Business, stand-alone community-based palliative care 
programs were not easily sustainable under the current CMS reimbursement policies because 
programs are only reimbursed for consultations.  Additionally, it was anticipated that 
reimbursement would continue to decline 1 to 1.5 percent in the next few years. The only 
financially advantageous feature of the palliative care program was a strategy to retain patients 
during their transition into the organization’s hospice program.   
The Hospice organization’s geographical location in the midwest significantly impacted 
the organization’s success.  The people within the organization’s region are known for their 
generosity and willingness to financially support organizations that benefit the community.  The 
hospice and palliative care organization receives substantial donations every year to grow their 
budget and meet expenses.  Without this generous financial community support, the organization 
would not be so financially secure. 
The midwest palliative care program provided care within different facilities.  The 
program served small community hospitals, assisted living facilities, and skilled nursing 
facilities.  Each of these facilities had different policies, procedures, structure, culture, and 
climate.  Whenever the organization’s providers entered different healthcare systems, the 
providers had to adapt to the facility’s expectations and requirements.  It was necessary for the 
providers to adapt to new rules, documentation, understand chains of command, and 
communicate appropriately and effectively to best meet patient and organizational needs.  
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Working in different systems also mandated varying credentialing requirements.  Therefore, each 
healthcare team member was credentialed to the highest level possible in order to meet the needs 
of each facility.  The relationships with outside facilities were vital and the midwest hospice and 
palliative care organization devoted significant time and resources to continue forming and 
strengthening professional ties.   
Mission and Strategy 
Evidence suggests merely having a written mission statement is important to 
organizational effectiveness (Burke & Litwin, 1992).  The declared mission states what is 
important to an organization and the strategy outlines how to fulfill the organization’s mission 
and purpose. The Burke-Litwin model not only assesses the mission and strategy of an 
organization, but also assesses the employee’s perception of these statements.   
The midwest hospice organization’s mission was to, “provide the most compassionate 
and highest quality end-of-life care through physical, emotional, and spiritual support.”  The 
vision was, “by delivering the highest quality of care for living, [the organization] is recognized 
as the most successful, preeminent hospice in [the state].”  The organization’s core values were 
“a passionate belief in: excellence, honest and integrity, sacredness of human life, and the unique 
contribution of each individual.” 
The mission statement, vision, and core values were clearly explained and discussed with 
all new hires.  Most desks and bulletin boards around the headquarters had these statements 
displayed.  The Executive Director and Director of Business believed the mission had formed the 
culture of the organization and they effectively retained the employees that had adopted the 
mission to guide daily work. 
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The hospice’s mission statement, vision, and core values had key themes that form the 
backbone of the organization.  During discussions with each member of the team the words 
“excellence,” “highest quality,” and “compassion” were regularly heard.  The organization 
believed in the importance of an interdisciplinary team approach to provide holistic care to show 
compassion, and to treat and relieve suffering.  The program hoped to reflect a spirit of caring 
that emphasized comfort and dignity for patients and families.  The organization believed in the 
sacredness of life and respecting people of all cultures, lifestyles, values, and wishes.   
The midwest palliative care team’s Registered Nurse and Social Worker believed that the 
palliative care program and hospice shared mission statements, core values, and vision.  
However, the Director of Business said there was a different vision for the palliative care 
program.  The lack of awareness of the palliative care program’s mission and vision by the 
program’s staff was a weakness of the organization.  The uninformed team members suggested 
that the team had little to no contribution to the development of the vision and mission of the 
palliative care program. 
Leadership 
Leaders provide direction and serve as role models for employees (Burke & Litwin, 
1992).  This factor deals with leadership processes, leadership styles, and employee perceptions 
of the leadership.  The midwest hospice and palliative care program as a whole believed that the 
team provided the highest quality, cost effective, and equitable care in the region.  By delivering 
the best care, the organization hoped to become the most successful preeminent hospice and 
palliative care team in the region.  The specific strategy to achieve this goal was developed by 
the Executive Director with the Director of Business.  Prior to implementation the strategies 
were discussed with the Board of Directors.  The strategies were highly protected and were not 
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discussed with the board or employees until time of implementation.  The highly guarded 
behavior and lack of transparency from upper management was frustrating to staff.  This process 
was non-negotiable and employees were given the opportunity to transition to new organizations 
if they could not accept the method of strategy development. 
 Prior to the tenure of the current Executive Director, the midwest hospice and palliative 
care organization was not financially sustainable.  The organization needed dramatic change for 
survival.  The current Executive Director had a reputation of success in these types of 
circumstances.  It is reported that the Executive Director initially used a coercive leadership 
style.  He demanded immediate compliance and made many large changes within the 
organization.  After the organization recovered from crisis the leadership style transitioned to 
authoritative in nature.  The Executive Director mobilized the team towards a common goal and 
mission.  The Executive Director invited new hires to join in the journey if the applicant fits well 
within the organization.  The expectations, mission, and leadership style was clearly defined for 
all new employees.  
Organizational Culture 
 Organizational “culture is the collection of overt and covert rules, values, and principles 
that are enduring and guide organizational behavior” (Burke & Litwin, 1992, p. 532).  An 
organization’s culture is an unspoken “meaning system” that is developed over time through an 
organization’s history.  The midwest hospice and palliative care program’s history was rooted 
firmly in faith.  The founders of the organization were affiliated with the Christian Reformed 
Church and felt a strong calling to treat and minister to the dying members of the community.  
Although the organization was not strictly faith based it claimed to be non-denominational and 
was committed to addressing the spiritual care needs of all patients and families.  A Christian 
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faith was not a prerequisite to be employed at the hospice and palliative care organization but 
many healthcare professionals had a strong faith that guided their care and work.  In the same 
way the organization ministered to all backgrounds and faiths while providing spiritual care 
desired by the patient and family. 
According to the Nursing Educator and the Director of Business, the arrival of the 
Executive Director 5 years prior to this project triggered a large culture change.  The Executive 
Director set clear expectations and created a list of rules for all employees to follow.  There were 
3 main themes throughout the employee manual that were required from all employees.  First, 
“arrive to work on time, if not early, giving [the organization] 100% effort when you are 
working; second, stay focused, do not spend time on issues you have no control over; and third, 
get along with your coworkers.”  Other topics included in the document were professionalism, 
effective communication, honesty, respect, and leading by example. 
Structure 
Structure is how people are arranged into specific areas and outlines responsibility, 
authority, communication, and relationships (Burke & Litwin, 1992).  Structure articulates 
hierarchy and who communicates and answers to whom.  The midwest palliative care program 
and the hospice program shared staff.  The Registered Nurse and Social Worker were the only 
employees that were solely designated for palliative care program.  The providers, Clinical 
Support Nurse, Patient Care Coordinators, Clinical Liaison, Community Liaison, Director of 
Business, Director of Quality and Education, Director of Counseling, Director of Finance, 
Billing Administrators, Director of Human Resources, and Executive Director were all shared 
between hospice and palliative care programs.  This made an organizational diagram very 
complex.  Nonetheless, the overall patient care team was very small and tightknit.  The lines of 
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communication, authority, and personal responsibilities were clear to those within the 
organization. 
Systems 
 Systems in the Burke-Litwin model represent the standardized policies and procedures 
that facilitate workflow and evaluation of outcomes (Burke & Litwin, 1992).  This concept 
addresses factors from reward systems and evaluation of outcomes to goal and budget 
development.  
The midwest palliative care team was the only community-based palliative care 
organization in the region with a physician-based model.  This system revolved around the team 
of physicians that guided treatments and conducted consultations.  Although this system and the 
roles of the supportive cast were clear the workflow, procedures, and policies regarding patient 
follow-up were ambiguous.  There was no system, standard, or procedure that guided patient 
follow up.  Furthermore, there was no consistent formal evaluation of outcomes.  For 2 years the 
program used the Edmonton Symptom Assessment Scale (ESAS) to measure symptoms and 
monitor outcomes.  The team did not believe the tool improved assessment or enhanced patient 
care and desired to adopt a new tool.  During the summer of 2016 the team decided to use the 
Palliative Outcome Scale to measure quality data to evaluate the program’s effectiveness.  
However, many providers found the tool cumbersome, the information derived irrelevant, and 
did not appreciate how the tool interrupted the natural workflow of the consultation.  As a result 
many providers did not use the tool and outcomes were poorly evaluated by a standard measure.   
Although the midwest palliative care team was consulted most for symptom management, the 
organization had not consistently utilized a standard measure of symptoms.  The lack of cohesion 
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and consistency made it difficult to determine effectiveness of the providers and of the program 
as a whole.     
Management Practices 
Management practices are how managers utilize resources to carry out the organization’s 
mission and strategy (Burke & Litwin, 1992).  This factor discusses behavior of managers and 
how they encourage employees to be creative and complete tasks and projects.   
Each quarter the managers and directors met to determine and evaluate goals for each 
team.  The goals had to surround 1 of 9 topic areas that contributed to meeting or exceeding the 
budgeted census.  The 9 topics that guided the creation of goals included; business principles 
expertise, exceptional quality care, high customer satisfaction, long-term relationship building, 
targeting our audience, create synergy, educate for expertise, hire the best, and benchmarking. It 
was believed that goals guided by these 9 topics would contribute to the organization’s mission 
of becoming the most successful and preeminent hospice in the state.  
 Each director managed the budget and determined department needs.  Human resources 
were managed within close relationships.  Each individual operated very autonomously but had 
support whenever needed.  The roles and expectations of each staff member were clearly 
articulated and understood.  Quick face-to-face meetings were encouraged and members of the 
team fed off each other’s performance.  The patient care managers were largely focused on 
determining patient needs and appropriate staffing oversight.  These managers functioned more 
day-to-day while directors oversaw larger, more strategic issues.  The managers matched supply 
and demand based on census.  The unsteady and ever-changing utilization of nursing staff had a 
large impact on the work-unit climate. 
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Climate 
The climate is the combination of impressions, expectations, and feelings of the staff and 
teams that impact relationships with peers, bosses, and other teams (Burke & Litwin, 1992).  The 
work-unit climate was not always stable at the midwest palliative care and hospice program.  
Staff contentment seemed to rely heavily on patient census.  The staff preferred to stay busy and 
active.  However, during long periods of high census the climate could be tense and the staff had 
a tendency to feel overworked.  A steady and manageable workload contributed to the highest 
employee morale.  Within the palliative care team communication and workload were the 2 most 
significant factors impacting the work climate. 
The leadership team was very open to change and appeared capable of effectively 
managing transitions.  According to the Nursing Educator and Quality Director this was not true 
prior to the tenure of the current Executive Director.  Change was reportedly once met with 
emotion and resistance.  A number of employees who could not tolerate change decided to seek 
new employment opportunities.  After a large leadership turnover the remaining team was 
excited about the trajectory of the organization. The team was capable of modifying practice and 
had become experts at adapting to the current situation or climate.  The team’s openness to 
change and the ability to be led created a positive working environment where creating the best 
patient experience was the focus. 
Task and Individual Skills 
 Task requirements and individual skills are the knowledge, skills, and abilities required to 
complete a task and meet a job requirement (Burke & Litwin, 1992).  This is often articulated as 
having an effective job to person match.  According to the organization’s goals and objectives, 
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“having the right people, in the right positions, doing the right things, at the right time, places the 
organization in the right direction.” 
The interview process for new hires was long and consisted of 3 different reviews.  An 
objective of the long process was that expectations were clear and the role understood.  Another 
main objective of the arduous interview process was that there be a solid job-person match.  The 
first interview was with the Human Resource Director.  The next interview was with the manager 
and at least 1 member of the team.  The final interview was with the Executive Director.  The 
midwest hospice and palliative care organization preferred to recruit rather than post jobs online.  
Management team members were always looking for hard to fill positions and accepted 
applications even when positions were not open.  This process focused on the long-term vitality 
of the organization and was proactive rather than reactive ensuring the right person for the right 
job. 
Individual Needs and Values 
Individual needs and values refer to the psychological factors that enhance an employee’s 
job satisfaction (Burke & Litwin, 1992).  This factor studies how employees derive worth from 
tasks and work.  Each individual has a set of values and beliefs.  When tasks are consistent and 
validate an employee’s beliefs, work can be enriching to life. 
All employees interviewed during the organizational assessment discussed the 
importance of alleviating suffering, providing quality care, and showing compassion.  The 
Registered Nurse stated that she felt most fulfilled when developing relationships with patients 
and alleviating fear.  The Marketing Director stated she felt most alive when overcoming 
obstacles and moving the organization forward.  The Marketing Director also enjoyed 
communicating effectively to make complicated things easier.  The Medical Director had a 
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mildly different perspective.  The Medical Director felt most valued and appreciated when he 
was able to make a meaningful difference in a patient’s life.  A large reason the Medical Director 
transitioned from emergency medicine into palliative care was to have a gentler patient to doctor 
relationship.  Whether through difficult discussions or optimal symptom management the 
Medical Director received fulfillment by leaving a meaningful impression in people’s lives.  
From Marketing Director to Medical Director and Registered Nurse the needs and values were 
consistent.  The employees of the hospice and palliative care program were most fulfilled 
through making a meaningful difference in people’s lives.   
Motivation 
 Motivation is the desire, incentive, or inspiration to complete a task (Burke & Litwin, 
1992).  Motivation is also described as the energy and power to achieve a goal in order to attain 
satisfaction.  This intangible factor is often generated through values and beliefs.  Therefore, 
there is significant overlap between employee’s values and motivation.   
Through interviews it was clear the members of the palliative care team were motivated 
to provide the highest quality care.   However, each individual had more specific factors that 
served as motivation.  For example, the Registered Nurse obtained the most satisfaction through 
impacting a patient’s day-to-day life but was specifically motivated by completing individual 
tasks and completing a daily checklist.  The Director of Quality and Education was motivated by 
working independently and utilizing a variety of skills to fulfill a large range of responsibilities.  
The directors were highly motivated by competition.  The directors deeply desired to be the best 
hospice and palliative care team in the region and the competition inspired them to action and 
stimulates new initiatives and strategies. 
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Individual and Organizational Performance 
The final factor of the Burke-Litwin organizational model of performance is a 
transactional factor (Burke & Litwin, 1992).  Individual and organizational performance is the 
culmination of all other factors and examines the results produced by the organization.   
The palliative care team used a variety of metrics to determine outcomes.  Possible 
palliative care metrics were patient census, number of completed advanced directives, 
effectiveness of symptom management, patient satisfaction, number of patient hospital visits, and 
number of patients who transition to the organization’s hospice program. 
The organization was measuring patient satisfaction through an online survey sent out to 
all patients.  Census, percentage of patients with advanced directives, and number of patients 
transitioning into hospice were monitored regularly.  The organization was not however, 
monitoring other quality indicators.  Measuring the organization’s ability to manage symptoms 
was an area of opportunity as symptom management is the most common reason for a 
consultation with the midwest palliative care team.  Unrelieved symptoms significantly impact a 
patient’s quality of life and ability to function (Cleeland et al., 2000).  Unpleasant symptoms 
profoundly alter and limit activities, negatively impact family relationships, impair work 
productivity, and decrease quality of life (Dodd et al., 2001).  A good symptom inventory is 
important and should improve symptom detection and treatment.  Thorough symptom 
assessment leads to more informed clinical decision making and more effective medication 
regimens.  Due to reimbursement procedures nurses and providers are not reimbursed for follow 
up patient interactions.  Within the reimbursement structure it becomes even more important to 
establish effective medication regimens that provide optimal symptom relief, which require less 
provider and nurse follow up.  Reducing follow up interactions saves providers time and 
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decreases cost. Additionally, providing quality care generates positive word of mouth marketing, 
which should increase patient census.  Providing quality care also increases retention of 
palliative care patients that transition to hospice care. 
SWOT Analysis of Organization 
The midwest hospice and palliative care team was studied analyzing strengths, 
weaknesses, opportunities, and threats (SWOT).  A SWOT analysis provides a quick and 
succinct model to identify areas of high performance and opportunities for improvement.  A 
SWOT analysis can help an organization capitalize on strengths and improve weaknesses. 
Strengths 
 The midwest palliative care team had a unique physician-based model.   The model 
ensured that patients saw a physician at the time of consultation and frequently during the first 
follow up.  A physician-based model places a larger workload on the physicians and can be more 
expensive, but the organization believed this leads to the highest quality of care.  There was also 
a culture of “going above and beyond” for patients.  This became the palliative care team’s 
reputation in the community and the staff fed off of this culture.  The palliative care team’s 
relationship with the hospice program expanded the services the palliative care program could 
provide.  After hours the on-call hospice nurse provided 24-hour support to meet palliative care 
patient’s needs.  The palliative care team had a fulltime social worker and if needed could access 
the hospice’s bereavement and pastoral care services as well.  The team had a reputation of 
seeing patients quickly.  In fact, it was common for patients to be seen the same day the referral 
was written.  
The palliative care team covered a large area providing care in home and in facilities 
spanning 5 counties.  The small team size was another strength of the midwest palliative care 
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program.  Patients with complex diseases and multiple comorbidities were exposed to many 
healthcare professionals and a multitude of specialists.  A small team streamlines communication 
and reduces the number of patient handoffs.  Due to the small size of the team, the patients 
consistently talked to the same professionals who had developed a relationship and knew the 
patient’s story. 
Weaknesses 
The midwest palliative care team’s 2 largest weaknesses were poor focus on advanced 
directives and inconsistency in gathering quality data.  During the spring of 2016, only a third of 
the palliative care patients completed an advanced directive.  This statistic improved but more 
work needed to be done to asess and assure patient’s wishes.  The organization’s difficulty 
gathering quality data had been discussed and was the focus of this quality improvement 
implementation project.  An additional weakness identified by multiple members of the palliative 
care team was the underutilization of the social worker.  Patients were not adequately screened to 
receive social work services.  The social worker had the most available time compared to other 
members of the palliative care team. 
The connection with the organization’s hospice program was confusing to many 
prospective patients and families.  The midwest hospice and palliative care team was not 
affiliated with a hospital or major healthcare system.  Many prospective patients perceived this 
as a weakness as well.  Patients with a terminal illness often utilize hospital services.  Each time 
a patient is hospitalized and discharged communication must occur between the hospital system 
and the palliative care team.  This transition of care creates opportunities for fragmented care and 
miscommunication.  Medication reconciliation and updates in the patient’s history must occur 
each time another entity initiates care.  Variations in electronic health records make information 
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 44	
sharing even more challenging.  Patients are often aware when care is poorly coordinated and 
poorly coordinated care increases the stress a patient experiences. 
Opportunities 
The most significant opportunity articulated by the palliative care team was supported in 
the literature.  A knowledge gap existed among community members and even primary care 
providers (M. A. Bakitas et al., 2015).  The organization was committed to allocating resources 
to provide education to the community and healthcare providers about the services palliative care 
could deliver.  The organization believed there was strength in a physician-based model and 
boasted of quick consultations following referrals.  However, there was poor community 
awareness about these strengths.  This was a significant opportunity for the organization to move 
forward. 
Threats 
Hospice and palliative care services were available through many organizations for 
persons seeking these services.  At the time of this project, a number of large hospital systems in 
the region were in the process of developing a community based palliative care program.  In an 
already saturated market, referrals for the midwest hospice and palliative care team could 
diminish.  Another hospice organization in the region offered unique services and was another 
competing organization.  This other hospice program had a hospice facility for patients who were 
unable to die at home.  And at this facility the other hospice organization had highly sought after 
designated Medicaid beds.  The Medicaid beds were in high demand and many patients signed 
on with the other hospice organization in the hope of securing one of these coveted beds.  In 
short, competition was the largest threat to the midwest hospice and palliative care organization. 
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SWOT of Proposed Intervention 
Strengths 
The midwest palliative care team identified the need for quality data regarding symptom 
experience.  The organization was highly motivated to implement a symptom inventory tool to 
improve symptom assessment, improve clinical decision-making, determine effectiveness of 
treatment regimens, and gather data on provider effectiveness.  The organization had a mission 
and strategy that strived for excellence, competitive leadership that wanted to be the best, a 
culture that accepted change, a system that needed quality data, and professionals that desired to 
improve performance. 
Weaknesses 
 The organization had previously failed to implement and sustain previous attempts to 
assess patient symptom experience through surveys and questionnaires.  These prior surveys 
failed because the tools were perceived as too time intensive, the information derived too 
irrelevant to the providers during consultation, and the tool interrupted the natural workflow of 
consultations.  Another potential weakness was the lack of policy and procedures outlining 
timeframes for patient follow-up.  The implementation strategy of this project created a new 
workflow and process requiring more frequent and structured patient follow-up.  
Opportunities 
 Generating quality data is important to present to third party payers, the CMS, and 
invested community stakeholders.  The midwest hospice and palliative care program received 
many sizeable monetary donations from persons who reside in the geographical area.  According 
to the hospice leadership, their charitable donors desire to see impact from the donations 
provided.  Generating and tracking quality data can also provide inter-provider accountability 
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and track the effectiveness of the prescribers.  Overall, gathering quality data increases 
accountability to patients, government, charitable donors, the community, and workers within the 
organization. 
Threats 
The organization’s prior failures to implement a symptom experience assessment tool, 
perceived lack of time during consultations, and the undefined follow up procedures were all 
possible threats to implementation.  Additionally, there was no clear accountability or incentive 
to incorporate this procedure into practice.  Implementation strategies were threatened until the 
palliative care team was able to observe a tool that has direct impact on patient care. 
Key Stakeholders 
 The key stakeholders of the midwest hospice and palliative care team consisted of the 90 
professionals, 200 volunteers, the Board of Directors, the charitable donors, the community, and 
the patients the organization serves.  The organization had a large community support base 
consisting of volunteers and donors.  According to the Executive Director, without the generosity 
of community donors the organization would not be sustainable.  The palliative care program 
rendered services that cost substantially more than the organization received annually.  In fact, 
the excess funds generated from the hospice program supplied for the financial losses of the 
palliative care program.  The organization did not make the decision to provide palliative care 
services because it was fiscally advantageous, rather palliative care was provided because the 
organization believed that palliative care services were needed in the community to improve the 
quality of life for patients impacted by life limiting illnesses. 
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Project Plan 
Purpose of Project 
The midwest hospice and palliative care organization had prioritized the measurement of 
symptom experience but had been inconsistent in utilizing a tool during consultation and follow 
up. Therefore, the purpose of this project was to implement and evaluate an evidence-based 
symptom inventory tool with 4 additional short answer questions in a community based 
palliative care program.  The symptom assessment tool provided a quality measure for the 
organization to assess outcomes. The short answer questions were used to identify trends and 
themes of perceived barriers to palliative care services by rural and non-rural patients.  Finally, 
the organization’s acceptance of the implementation was evaluated through staff questionnaires.  
The proposed project had 2 objectives: 1) meet the organization’s needs of generating 
quality data, and 2) improve understanding of rural populations and the challenges the population 
experiences in accessing palliative care services.  The organizational objectives of this project 
were: 1) identify a symptom inventory tool that met the needs of the organization, 2) create an 
evidence-based project design with follow up recommendations, 3) guide implementation, 4) 
evaluate the protocol’s effectiveness, and 5) provide recommendations to sustain the project.  
The objectives focused on rural populations included: 1) determine the duration of time a patient 
suffered from unpleasant symptoms prior to obtaining access to services, 2) identify patient 
perceived barriers to receiving palliative care, 3) determine what mode of communication was 
effective in educating the patient on palliative care, and 4) determine the patient’s perceptions of 
geography and access to services.  
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Type of Project 
 This project was a quality improvement initiative.  The project’s primary objective was to 
implement a symptom inventory tool to provide quality data to track the palliative care 
program’s effectiveness in managing patient symptoms.  Another primary objective of the 
project was to gather insights regarding the impact of demographics on patient perceived barriers 
to accessing palliative care services.  Therefore, an additional questionnaire was administered at 
consultation to identify themes for both rural and non-rural patients in palliative care barriers and 
utilization.  A secondary objective of the proposed project was quality improvement through 
improved assessment.  Frequent standardized assessment of patient symptoms has the potential 
to enhance provider effectiveness and improve patient care (Ripamonti et al., 2012).   
Setting and Needed Resources 
The midwest hospice and palliative care program was a non-profit, Medicare-certified, 
Joint Commission accredited hospice organization.  The palliative care program was a member 
of the Center to Advance Palliative Care (CAPC).  The hospice and palliative care team was 
located in the midwest but provided care in the home, clinic, and in many facilities across the 
region.  The organization’s service area spanned 5 surrounding counties. 
The implementation of this quality improvement initiative required 900 dollars to 
purchase the MDASI in English and Spanish; this cost was absorbed by the organization.  
Additional needs for the proposed project included a phone to make phone calls, a computer, and 
secure email access to communicate about new consults and discuss follow up information.  
Budget 
The MDASI core inventory in English cost 100 dollars per healthcare provider.  The 
midwest palliative care team requested a Spanish form of the symptom inventory as well, which 
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cost an additional 100 dollars per provider.  The organization had 4 providers.  With the addition 
of an administration fee the overall cost of implementation was 900 dollars. The MDASI was 
purchased by the organization in anticipation of long-term use.  
Project Design 
After thorough consideration of a handful of tools and an evaluation of the needs of the 
organization, the palliative care team chose the MDASI to measure symptoms and evaluate the 
palliative care team’s performance.  The doctoral student conducted phone calls to patients to 
administer the MDASI and the perceived barriers questionnaire.  The perceived barriers 
questionnaire was administer following the administration of the MDASI during the first 
interaction only.  The MDASI was administered: 1) within 48 hours of consultation to determine 
symptom burden, 2) 3-7 days after consultation, 3) every medication regimen change, 4) 3-7 
days after a medication regimen change, and 5) 1 month following consultation.  Rationale for 
patient follow-up was discussed in the “Measuring Symptoms” section.  Start and stop times of 
MDASI administration was documented to determine administration time.  Frequency of 
MDASI administration was also monitored.  Following each phone call the completed MDASI 
was sent via email to the palliative care team’s Registered Nurse for review and to upload the 
MDASI into the electronic health record.  Any additional information regarding the patient was 
communicated to the team through the organization’s encrypted email, over the phone, or face-
to-face.  A staff questionnaire was administered midway through the implementation project to 
all healthcare professionals within the palliative care program to evaluate objectives 
The midwest hospice and palliative care team spanned 5 counties.  According to the 
United States Census Bureau 2 of the 5 counties are considered rural (US Census Bureau, 2015).  
The remaining 3 counties the program served are considered non-rural.  Patients that completed 
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the perceived barriers questionnaire were separated into rural and non-rural subgroups by county 
of residence.  
Ethics and Human Subjects Protection 
The Grand Valley State University Human Research Review Committee determined that 
this project was not human research.  The project was a quality improvement initiative designed 
to improve symptom assessment, provide symptom management quality data, and increase 
understanding of patient perceived barriers to palliative care services.  Similar to all quality 
improvement initiatives, patient data was collected and subject to confidentiality regulations.  
Data was maintained safely within the organization’s offices.  A door requiring keycard access, a 
locked office, and a password-protected computer protect patient data.  The doctoral student 
obtained the patient’s name and county of residence upon consultation.  All patient identifiers 
were removed and sensitive information was translated into code.  The patient-identifying key 
was stored on the organization’s computers and was not removed from the site at any time.  
Information was shared between the palliative care staff using the organization’s secure email 
account, over the phone, or face-to-face.  During statistical analysis an encrypted thumb drive 
was used to transport data to the University’s statistics department.  After the scholarly project 
was uploaded into Scholar Works all information was given to the organization via encrypted 
email and information was deleted and destroyed. 
Participants and Sampling 
Participants included all English-speaking patients living at home or in assisted living 
facilities referred to palliative care services for symptom management.  Additional inclusion 
criteria included the ability to self-report symptoms.  Implementation began February 15, 2017 
and ended April 7th upon completion of 25 qualitative questionnaires.  Consults from skilled 
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nursing facilities or hospitals were not included in the sample.  Patients in hospitals were 
excluded from participation because the scholarly project focused on the community-based 
patient population.  Patients residing in skilled nursing facilities were excluded due to feasibility 
concerns.  Based on the experience of the palliative care practitioners, they felt that many 
patients residing in skilled nursing facilities are unable to self-repot symptoms due to cognitive 
abilities.  Additionally, many of the skilled nursing facility patients do not have access to a 
phone.  Therefore, administering the MDASI with patients would require time from the skilled 
nursing facility staff adding to the staff’s workload.  To fulfill the objectives of the project in 
implementing and evaluating a symptom experience tool, the palliative care practitioners wanted 
to avoid data that could confound the implementation.  Persons in skilled nursing facilities will 
be considered at a later date. 
Measurement 
The MDASI was the primary measurement tool utilized in the proposed project.  The 
answers to patient perceived barrier questions were synthesized to draw themes.  Symptom 
scores were gathered and changes in scores monitored over time.  The frequency of tool 
administration was counted, the amount of time used to administer the MDASI was calculated, 
and the project’s acceptability by staff was measured via the “MD Anderson Symptom Inventory 
Implementation Questionnaire.”  
Steps of Implementation 
The project commenced on February 15, 2017.  All new referrals were called and surveys 
were administered.  Patients were enrolled in the project on a rolling basis.  On March 15, 2017 
the “MD Anderson Symptom Inventory Implementation Questionnaire” was administered to 
determine the staff’s opinions regarding the implementation and to guide a plan for 
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sustainability.  The scholarly project ended data collection on April 7, 2017 upon completion of 
the 25th patient perceived barrier questionnaire. 
Project Evaluation Plan 
The project was evaluated in a number of ways.  Frequency of tool utilization per patient 
and time to complete the MDASI were calculated.  A staff questionnaire was administered on 
March 15, 2017 to all healthcare professionals within the palliative care program to evaluate 
objectives, determine workforce opinion, and to guide the sustainability plan. Questions in the 
staff questionnaire were posed in Likert format and are available in Appendix I.  The questions 
asked the palliative care team: 1) whether the MDASI provided timely and helpful information; 
2) contributed to assessment of symptoms; 3) effectively evaluated medication regimen 
effectiveness; 4) whether follow up intervals were practical and effective; and 5) whether the 
MDASI and protocol should be sustained in the organization. 
Project Outcomes 
Overall, 29 referrals were sent to the midwest palliative care program between March 15, 
2017 to April 7, 2017.  Of the 29 referrals, the MDASI was administered and completed by 19 
patients and the qualitative analysis of patient perceived barriers was completed by 25 patients.  
Of the 19 patients surveyed with the MDASI, only 10 were consulted early enough in the quality 
improvement initiative to be followed for a month.  However, among these 10 patients only 6 
completed an MDASI at 1-month post consultation.  Of the 19 patients referred for palliative 
care services 15 were referred for pain, 3 for shortness of breath, and 1 for fatigue.  
 Of the 29 patients referred for palliative care services, 5 were rural and 24 were non-
rural.  Approximately 72% of the perceived barrier questionnaire responders resided in Ottawa 
County.  A pie chart of the counties represented in the qualitative analysis is available in 
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Appendix J.  Of the 25 patients surveyed with the perceived barriers questionnaire 4 lived in an 
assisted living facility, during implementation 2 patients transitioned from palliative care into 
hospice care, and 2 patients deceased during the scholarly project.  The qualitative questionnaire 
provided information regarding patient perceived barriers to palliative care services and the 
implementation of the MDASI provided population characteristics of patients referred for 
palliative care services. 
MD Anderson Symptom Inventory Administration 
Of the 19 patients that completed the MDASI, 15 patients sought consultation for pain 
management.  The patients consulted for pain were in significant distress with an average pain 
rating of 7.93 out of 10 at time of consultation.  However, the palliative care team was able to 
provide patients with considerable relief.  Patients who were consulted for pain and had a follow 
up interaction in 1 week reported a mean 6-point improvement of pain. Appendix K presents a 
boxplot of patient reported pain at consultation, Appendix L presents a table of patient reported 
pain at consultation, and Appendix M presents a table of pain improvement measured with the 
MDASI. 
The symptom cluster of pain, fatigue, and distress are frequently studied in literature.  
These symptoms as well as the interference of enjoyment of life inventory item were studied 
closer to learn patient characteristics and determine program effectiveness.  Of the 19 patients 
that completed at least one MDASI the mean fatigue score at consultation was 6.74 out of 10 and 
the average distress score was 5.47 out of 10.  On a scale of 0 to 10 patients were asked how 
much symptoms interfered with enjoyment of life.  A score of 0 implied symptoms did not 
interfere at all and a score of 10 implied symptoms interfered with enjoyment of life completely.   
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The average response to the inventory item was 6.84 at consultation.  Appendix N presents these 
symptom scores at consultation. 
 A key objective of the project was to provide a symptom inventory that gathered quality 
measures to monitor the program effectiveness in managing symptoms.  During implementation 
6 patients were followed for a month.  Symptom improvement was studied in these patients at 1 
week compared to baseline and 1 month compared to baseline.  At 1 week the patients 
experienced: a mean improvement of pain by a score of 2.67; improvement of fatigue by a score 
of 1.17; improvement of disturbed sleep by a score of 0.83; and a decrease of symptom 
interference on enjoyment of life by a score of 0.67.  At 1 month the symptom reductions 
observed were sustained and reduced further.  In fact, at 1-month pain scores were improved on 
average by 3.5 compared to baseline; fatigue scores improved on average by 1.67; disturbed 
sleep scores improved by 3; and interference of enjoyment of life scores improved on average by 
2 points.  Appendix O presents a table of improvement of MDASI scores at 1-week compared to 
consultation and Appendix P presents a table of improvement of MDASI scores at 1-month 
compared to consultation. 
The number of patients observed is far too small to imply significant results or draw 
generalizable information.  The objective of the scholarly project was to create a means to 
generate and gather quality data.  The organization needed a method to monitor program 
effectiveness in order to have reportable data.  The results obtained during the quality 
improvement initiative provided evidence that the MDASI met the organization’s objectives of 
generating quality data and tracking performance.   
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Patient Perceived Barriers to Palliative Care Services 
Immediately following the administration of the MDASI, 4 short answer questions were 
posed to patients during the consultation phone call.  A thematic analysis was conducted on the 
qualitative questionnaire to examine and record patterns observed in responses.  The doctoral 
student transcribed responses during the phone call.  During analysis responses were coded to 
determine frequencies and co-occurrences.  Finally, themes were induced and patterns are 
discussed below. 
How long have your symptoms affected your life?  When reporting duration of time 
symptoms affected a patient’s life, 5 patients reported duration in years and 20 reported duration 
in months (symptoms affected life less than 1 year).  Of the 20 patients reporting duration in 
months, 3 patients reported that symptoms have affected life for years but clarified that 
symptoms have worsened within a time described in months.  Additionally, 3 more patients that 
reported duration of symptoms in months clarified by saying, “pain got worse,” “pain was up and 
down until,” or “pain got out of control” prior to providing a duration of time in months.  The 20 
patients that described duration of symptoms in months reported an average duration of 
symptoms lasting 4.45 months prior to receiving a referral for palliative care.  The 5 patients that 
described duration of symptoms in years reported an average duration of symptoms lasting 3.9 
years prior to obtaining palliative care services.  Interestingly, the 3 patients that suffered the 
shortest duration of time prior to obtaining a palliative care consult experienced an acute event 
that led to quick onset of symptoms and a quick referral. 
What has kept you from receiving palliative care before now?  A number of barriers 
were perceived and reported by patients.  The most frequently reported barrier to palliative care 
was lack of knowledge of the existence and role of palliative care.  In all, 17 patients did not 
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receive palliative care sooner because of this knowledge gap.  Of these 17 patients, 15 responded 
identically by saying, “I didn’t know about it.”  The remaining 2 patients said, “I never thought 
about it” and “I didn’t know where to start.”  This is the strongest theme induced by the thematic 
analysis.  The remaining themes were only shared by 1 or 2 responders.  Of these, 2 patients did 
not seek palliative care sooner because patient and family wanted to manage symptoms through 
additional healthcare support such as home care or assisted living.  Lastly, 2 responders reported 
there were no barriers.  Both patients had a very short duration of symptoms and attained a 
referral and consult quickly. 
All other barriers were only reported by a single patient.  A patient admitted to under 
reporting symptoms to the primary care provider (PCP) and said, “I didn’t tell him how bad I 
was.  There were a lot of things I didn’t tell him.”  The patient stated that she had felt poorly for 
a long time.  She finally received palliative care after honestly talking to her PCP about her 
symptom burden.  The issue of under reporting symptoms was identified during the literature 
review and validates the need for a quality symptom assessment tool (Kerr, Tangeman, et al., 
2014).  A patient residing in a rural community received a palliative care referral from the 
treating oncologist.  The patient stated that, “there was nothing the doctors could do for me.”  
This patient did not receive palliative care earlier because the oncologist wanted to be 
responsible for controlling the patient’s treatments and symptoms.  This patient reported duration 
of pain affecting life in years and had a substantial symptom burden.  Palliative care was not 
utilized sooner for 1 patient because family was not prepared to accept palliative care services.  
The patient’s wife admitted she was not ready for palliative care - as if accepting palliative care 
services was admitting defeat.  When asked, 1 patient responded that palliative care services 
were not attained earlier because the patient lacked a PCP.  As soon as the patient was able to 
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access a PCP a palliative referral was obtained.  Lastly, a rural patient’s PCP wrote a palliative 
care referral for the patient without notifying the patient and wife of the referral and without 
having a discussion about palliative care.  The wife was upset about the consult and became 
defensive about the care she provides the patient.  The wife argued that she provides adequate 
care for the patient and did not need help.  After a long discussion about palliative care’s role the 
wife believed palliative care was not needed or desired. 
How did you learn about palliative care?  Patients learned about palliative care most 
frequently from a PCP.  Specifically, 9 of the 25 patients learned about palliative care from the 
patient’s primary care provider.  An analysis of co-occurrences deduced that 4 of the 5 patients 
that reported symptom duration in years learned about palliative care from a PCP.  Although 
positive that patient’s PCPs are educating patients regarding palliative care this co-occurrence 
would suggest that perhaps PCPs are waiting too long to consult palliative care services.  
Oncologists were the second most frequent source of palliative care knowledge, educating 4 
patients.  Education also came from home health nurses (3 patients); friends and family members 
(2 patients); in-patient non-palliative care healthcare staff (2 patients); other specialists (2 
patients); in-patient palliative care team (1 patient); and on the phone with doctoral student (1 
patient).  A patient knew about palliative care already because she was once a hospice nurse.  
Patients were educated about palliative care from a multitude of different sources.  No strong 
relationships were identified between barriers to palliative care and source of education about 
palliative care services. 
Do you believe where you live impacted your ability to receive palliative care?  All 
25 patients responded “no” to this question.  In addition to reporting “no,” 2 patients believed 
living in an assisted living facility improved access to palliative care services and 1 patient 
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believed living in Ottawa County improved the patient’s capability to know about and access 
palliative care services.  Weaknesses of this question are discussed in the “Implications for 
Practice” section. 
Characteristics of rural populations.  Rural patients were highly hesitant to discuss 
health related information over the phone.  Of the 5 rural patients referred for palliative care 
services, all were skeptical of the doctoral student’s motives and only 1 patient was willing to 
participate in the MDASI.  As discuss earlier, a rural patient declined palliative care after being 
referred to palliative care without a discussion with the PCP.  This patient and wife were 
extremely skeptical of palliative care and perceived the referral as an insult to the spouse’s 
ability to care for the patient.  A couple patients refused to provide any information to the 
doctoral student.  A patient refused to provide any information because “[He] never [discusses] 
personal information over the phone.”  The patient asked the doctoral student, “How can I know 
that you are who you say you are?”  The next day the provider drove to the patient’s home to 
conduct the consultation and the patient refused to let the doctor inside.  The patient asked the 
physician to return another day.  During a phone call the patient answered the phone and 
abruptly said, “You’ll need to talk with my wife.  She handles all of my medications.”  Before 
being able to respond the phone was handed to the patient’s wife.  After describing the 
importance and relevance of the symptom inventory the wife and husband refused to participate 
because, “it’s been a long day and [the patient] isn’t feeling up to it.  We would rather share this 
information one time and directly to the doctor tomorrow.”  The wife argued that it did not make 
sense to tell multiple people the same story.  During another phone call attempt to reach a rural 
patient, the mother answered the phone.  The mother did not want the patient to be burdened by 
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the questionnaires and believed the information was too intimate to share over the phone without 
an established relationship with the staff or program. 
 Although, only 3 rural patients responded to the qualitative questionnaire of patient 
perceived barriers, 2 of them learned about palliative care during an inpatient admission.  Also 
noteworthy, similar to information found during the literature review at least 4 patients had 
strong family support (Hughes et al., 2004).  Early into each phone call with rural patients and 
family members it was clear that 4 patients received care from an informal caregiver.  An 
individual had a very supportive mother and 3 patients had a highly invested spouse.  The 
answers from the questionnaire were not thematically remarkable or different between rural and 
non-rural patients.  The overall interactions however varied greatly between rural and non-rural 
populations.  During implementation patients were not able to participate with the MDASI or the 
patient perceived barriers questionnaire for a number of reasons.  However, only patients 
residing in rural communities refused to participate.  The patients residing in rural areas were 
more skeptical of healthcare, hesitant to share information, and more likely to have an invested 
family member as the primary caregiver. 
Evaluation of MDASI Acceptability 
The scholarly project was evaluated in a number of ways.  Frequency of tool 
administration per patient and time to complete the MDASI were calculated.  A staff 
questionnaire was distributed to evaluate project objectives and to determine palliative care staff 
opinion regarding the scholarly project.  The 10 patients consulted early enough in the quality 
improvement initiative to be followed for a month were observed for frequency of tool 
administration.  The MDASI was administered to the 10 eligible patients an average of 2.9 times. 
The administration of the MDASI took an average of 6 minutes and 27 seconds with a median of 
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5 minutes and 55 seconds.  The minimum administration time was 3 minutes and 1 second and 
the maximum administration time was 11 minutes and 25 seconds.  According to Cleeland et al. 
(2000) administration of the MDASI requires an average of 5 minutes to complete.  
Administration time was longer during the scholarly project.  This difference in time to 
administer the MDASI is likely due to patient tendencies to share additional information beyond 
the questions of the symptom inventory.  A frequency table of MDASI administration is 
available in Appendix Q and a descriptive table of time to administer the MDASI is available in 
Appendix R. 
The number of patients observed is far too small to imply significant results or draw 
generalizable information.  The objective of the scholarly project was to create a means to 
generate and gather quality data.  The organization needed a method to monitor program 
effectiveness in order to have reportable data.  The results obtained during the quality 
improvement initiative provided evidence that the MDASI met the organization’s objectives of 
generating quality data and tracking performance.   
The staff questionnaire was the final mode of project evaluation.  All 5 palliative care 
team members completed and returned the survey.  Responders included 2 physicians, 2 
registered nurses, and 1 social worker.  The staff as a whole agreed strongest that “the MDASI 
contributed to the assessment of patient symptoms” and “the MDASI was effective in evaluating 
medication regimen effectiveness/patient condition.”  The weakest agreement of the staff 
questionnaire was that “the administration and follow up intervals of the MDASI were practical 
and effective for patient care and monitoring.”  One respondent disagreed with this question and 
wrote on the survey, “frequency is an issue” believing the MDASI was administered too 
frequently.  Other than this one disagreement response all other respondents agreed or strongly 
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agreed with each item on the implementation staff survey.  The responses to the staff survey 
guided the sustainability plan and will be discussed below.  Appendix S contains a bar graph 
depicting the means and standard deviations of responses to the staff questionnaire. In general, 
this project met the needs of the organization,  
Sustainability Plan 
The palliative care team struggled to consistently utilize prior quality measurement tools 
in place.  Palliative care staff attributed the failed implementation attempts to the previously 
implemented tools.  The providers believed the correct tool would be worth utilizing.  To combat 
this barrier the palliative care team decided together to utilize and implement the MDASI.  The 
perception of the tools was one barrier but another complaint regarding prior implementations 
was the disruption of the workflow during consultation.  The palliative care providers were 
frustrated with the time to administer the tools and felt transitions prior and following the tool 
were cumbersome.  To alleviate this barrier the providers themselves did not distribute the 
questionnaire or gather data. 
During the implementation process the doctoral student completed the MDASI over the 
phone.  Following the completion of the project the Registered Nurse continued to complete the 
MDASI over the phone.  During the organizational assessment, multiple time-consuming 
responsibilities of the Registered Nurse were identified that could be completed by another 
employee.  Many of these tasks did not require a Registered Nurse’s knowledge or expertise.  
The doctoral student communicated to the organization that reallocating tasks would better 
utilize the Registered Nurse and was essential for the sustainability of this project.  Intead of 
reallocating tasks, the organization elected to hire an additional fulltime Registered Nurse to 
improve the workload and ensure sustainability of the quality improvement project. 
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During implementation the Registered Nurses voiced concern regarding the workload of 
administering the MDASI prior to and following every medication regimen change.  This 
concern resulted in a change in frequency of MDASI administration.  Therefore, the organization 
agreed to administer the MDASI at consultation, 1 week following consultation, 1 month 
following consultation, and each month thereafter.  The MDASI would continue to be 
administered and uploaded into the patient’s electronic health record and the quality data would 
be maintained by the Director of Quality and Education.  The Doctor of Nursing Practice (DNP) 
project is the culmination of the DNP education experience and is a final opportunity to learn, 
grow, and display the essentials in practice within a functioning organization.  The DNP 
essentials utilized within this scholarly project are discussed below. 
Doctor of Nursing Practice Essentials 
The DNP essentials were established to outline fundamental curricular competencies in 
Doctor of Nursing Practice (DNP) programs (American Association of Colleges of Nursing, 
2006).  The achievement and growth of the 8 competencies are attained in a number of ways 
throughout the DNP program.  
Essential I: Scientific Underpinnings for Practice 
 Essential I is the scientific underpinning for practice competency.  This essential 
demonstrates an understanding of complexity of practice and the conceptual foundations of 
nursing (American Association of Colleges of Nursing, 2006).  This essential was demonstrated 
in this project by the utilization of nursing theory as a conceptual framework for the phenomenon 
of unpleasant symptoms and through the utilization of an implementation model.  Essential I was 
also fulfilled through the evaluation of symptom literature and, in response, the development of a 
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 63	
new strategy to assess and monitor patient’s symptoms.  Finally, this essential was demonstrated 
through evaluation of the implemented strategies.   
Essential II: Organization and Systems Leadership for Quality Improvement 
 Essential II is the organization and systems leadership for quality improvement and 
systems thinking competency (American Association of Colleges of Nursing, 2006).  Conducting 
an organizational assessment using the Burke-Litwin Model enacted this essential.  This project 
also demonstrates essential II by providing a means of accountability for the organization’s 
performance in managing symptoms.   This quality improvement initiative provides quality data 
that can be monitored by the organization, reported to government agencies, and used for 
advertisement purposes.  Throughout the implementation process the doctoral student enacted 
essential II through advanced communication skills and through leadership of the quality 
improvement initiative.   
Essential III: Clinical Scholarship and Analytic Methods for Evidenced-Based Practice 
 Essential III is the clinical scholarship and analytical methods for evidence-based practice 
competency (American Association of Colleges of Nursing, 2006).  This essential was 
demonstrated through critical appraisal of pertinent literature and by evaluating current practices 
within the organization.  The organization’s assessment techniques, processes, and follow up 
procedures were analyzed to guide the quality improvement initiative.  The quality improvement 
initiative methodologies were also evaluated to promote effective, efficient, and equitable patient 
care, further utilizing essential III.  The doctoral student was a collaborative consultant for the 
organization to improve symptom assessment and to provide quality data.  Lastly, uploading the 
scholarly project into Scholar Works will enact essential III through disseminations of findings. 
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Essential VI: Interprofessional Collaboration 
 Essential VI is interprofessional collaboration for improving patient and population 
health outcomes competency (American Association of Colleges of Nursing, 2006).  This 
essential was enacted by frequent communication with all members of the palliative care team.  
In addition, the doctoral student led the palliative care team in discussions of symptom 
management, available symptom inventory tools, and presented evidence of the importance of 
routine symptom assessment with a standard tool. 
Essential VII: Clinical Prevention and Population Health 
 Essential VII is clinical prevention and population health for improving our nation’s 
health competency (American Association of Colleges of Nursing, 2006).  This essential was 
exhibited in a number of ways during the scholarly project.  Palliative care’s ability to accurately 
and thoroughly assess and treat symptoms improves the quality of life of this population (Hui et 
al., 2014).  The purpose of this quality improvement initiative was to improve symptom 
assessment to further improve quality of life for the palliative care population.  Determining 
barriers to palliative care and examining themes between rural and non-rural patients is another 
way this essential was enacted.  Improved knowledge regarding barriers to palliative care can 
guide strategies to reach populations with poor access to improve population health and quality 
of life. 
Essential VIII: Advanced Nursing Practice 
 Essential VIII is advanced practice nursing expertise competency (American Association 
of Colleges of Nursing, 2006).  This essential was enacted through personal engagement with 
patients over the phone.  During phone interactions the doctoral student assessed multiple 
symptoms, quality of life, and distress.  Communications regarding symptoms and disease 
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progression required tact, discernment, and sensitivity.  Over the phone the doctoral student 
needed to be perceived as professional, compassionate, and trustworthy.  After multiple 
interactions, relationships were built with patients.  Essential VIII was further enacted through 
educating the Registered Nurses on information learned during the quality improvement 
initiative.  Lastly, this essential was enacted during the scholarly project by utilizing conceptual 
and analytical skills to evaluate and understand links in practice, populations, and policies. 
Implications for Practice 
Palliative care services are provided in an assortment of settings including hospitals, 
outpatient clinics, rehabilitation facilities, assisted living facilities, skilled nursing facilities, and 
inside patient’s homes (Meyers, Kerr, & Cassel, 2014).  Community-based palliative care is a 
comprehensive and multidisciplinary service that follows patients across the disease trajectory 
through transitions of care and a variety of healthcare settings (Kamal, Currow, Ritchie, Bull, & 
Abernethy, 2013).  Community-based palliative care teams have the advantage of seeing a 
patient’s environment to further individualize care and extend care to meet the need of patients 
with life limiting illnesses who are home bound.  This home-based approach is an opportunity to 
reach rural populations and improve the care these patients receive. 
A significant component of palliative care and its success on patient outcomes is the 
ability of the team to manage distressing symptoms (Hui et al., 2014).  Unpleasant symptoms 
impact almost every facet of a patient’s life and impairs functional capacity and increases 
patient’s distress (Carlson et al., 2012; Cleeland et al., 2000).  Patients struggling with a life 
threatening illness have a right to good symptom management.  In order to provide the best care, 
symptoms must be measured regularly and accurately.  A quality symptom inventory identifies 
symptoms, measures severity, and is sensitive enough to detect responses from treatment 
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(Cleeland et al., 2000).  Although no symptom inventory is perfect, the MDASI best suited the 
needs of the midwest community based palliative care team. 
Successes 
 The quality improvement initiative established and implemented a sustainable plan to 
obtain quality measures, improve symptom assessment, and standardize patient follow up 
procedures.  By implementing the MDASI the organization can learn about its patient’s 
characteristics, track provider effectiveness, and report the program’s performance to community 
stakeholders. 
 The qualitative analysis on patient perceived barriers to palliative care is consistent with 
the concerns already noted in literature.  Patients in both rural and non-rural communities are 
suffering from unrelieved symptoms for long durations of time prior to receiving palliative care.  
The qualitative analysis was also consistent with literature that suggests a knowledge gap in 
communities.  The overwhelming majority of patients did not receive palliative care before 
referral because the patient or family “didn’t know about it.”  Although this knowledge is not 
new, it validates the need for improved widespread education of palliative care’s existence and 
role.  The qualitative analysis also noted a difference in trust between rural and non-rural 
patients.  Rural patients were less trusting, more skeptical, and more reluctant to discuss sensitive 
matters such as health without an established relationship.  According to the literature, rural 
patients receive more informal support and caregiving than non-rural patients (Hughes et al., 
2004).  Prior to analysis the difference in caregiving was thought to be a result of limited 
resources.  Perhaps the skepticism towards outsiders or strangers is also responsible for 
differences in caregiving structures between populations.  
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Difficulties 
There were a number of challenges to overcome during implementation.  The most 
consistent challenge was developing trust and establishing rapport with patients quickly over the 
phone.  In most cases the doctoral student was the first palliative care team member to talk with 
the patient.  It was the doctoral student’s responsibility to create a positive first impression and 
establish a relationship.  It may be uncomfortable to have intimate discussions regarding health, 
disease trajectory, and burden of symptoms.  It can be even more uncomfortable to have such 
discussions with a stranger over the phone.  Therefore, it was crucial that each patient was 
assured that the doctoral student was competent, trustworthy, and compassionate.  At times 
fostering a quality relationship was more important that receiving quality data.  When patients 
were resistant to providing sensitive information over the phone this hesitancy was respected. 
Many patients were fatigued, distressed, and in pain.  These patients have limited energy 
to offer.  This was a significant barrier to participation.  Additionally, many patients see a 
multitude of healthcare providers.  Prior to provider visits patients are often required to fill out 
forms and questionnaires.  Repeated web-based, telephone, and paper-based questionnaires can 
create survey fatigue (Olson, 2014).  Providing relevance to the questionnaires and emphasizing 
the importance of the information obtained was challenging but essential to encourage 
participation.  Still, many patients elected not to participate with the qualitative questionnaire and 
the MDASI.  Patients’ hesitancy to discuss personal information, the decision to decline 
participation due to fatigue and distress, and the overall number of home-based referrals 
contributed to the final challenge of obtaining a satisfactory sample size. 
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Strengths 
The midwest hospice and palliative care organization has attempted to gather quality data 
in the past but had been unsuccessful for multiple reasons.  This quality improvement initiative 
provided the organization an opportunity to trial a symptom inventory, observe the 
implementation protocol in action, and determine limitations and weaknesses prior to committing 
organizational time and energy.  Following the implementation the organization had an 
opportunity to sustain the project or move in another direction.  The organization has elected to 
continue the implementation but made a few adaptations to the follow up procedures as a 
response to information learned during implementation.  Because of workload and logistical 
concerns the organization has elected not to administer the MDASI prior to and 1-week 
following medication regimen changes.  The organization’s ability to make necessary 
adjustments prior to adopting the protocol is a considerable strength and improves the likelihood 
of sustainability and a successful implementation. 
Another strength of the scholarly project is the clarity of themes noted in the qualitative 
analysis of perceived barriers to palliative care.  The analysis suggests patients suffer from 
distressing symptoms for an extended period of time prior to obtaining a palliative care referral.  
Additionally, the majority of patients did not receive palliative care services sooner because of a 
knowledge gap regarding palliative care’s role and existence.  This information provides urgency 
for educating the community about palliative care.  The knowledge gleaned from this analysis 
can also guide marketing and education strategies.  The questionnaire provided insights 
regarding how patients learned about palliative care and what prevented patients from accessing 
services sooner.  The organization can utilize this information to determine what modes of 
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communication are reaching patients and perhaps develop strategies to educate prospective 
patients sooner. 
Weaknesses 
The scholarly project had a number of weaknesses.  The first weakness was the number 
of participants reached for the quality improvement initiative.  The organization experienced an 
uncharacteristically low number of community based referrals during the implementation period.  
The project also experienced a large number of patients electing not to participate as well as a 
large attrition rate following the first interaction.  Of the 29 patients referred for symptom 
management, 10 did not participate with the MDASI at consultation.  Patients did not participate 
with the MDASI because 1 was too weak, 1 was unable to communicate clearly over the phone, 
2 were admitted to the hospital prior to consultation, 1 could not be reached despite many 
attempts, 1 passed away prior to consultation, and 4 patients refused.  Although 10 patients did 
not participate with the MDASI, 6 of these patients completed the qualitative questionnaire or 
had family answer the questions on the patient’s behalf. 
A number of patients were lost to follow up after completing an initial MDASI.  In all, 3 
patients refused follow up surveys due to survey fatigue, 2 patients transitioned to hospice care, 2 
patients deceased, and 5 patients only completed 1 MDASI because the scholarly project was 
completed prior to the 1 week follow up interaction. 
Lastly, another weakness of the scholarly project was the missed interactions prior to 
medication regimen changes.  On 2 occasions medication regimen changes were made prior to 
the administration of the MDASI.  On 1 occasion a patient called the weekend on call nurse 
regarding a pain crisis.  A medication regimen change was made over the weekend and the 
doctoral student was not notified until 3 days later.  On another occasion the physician spoke 
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directly to the patient during a follow up interaction and made medication changes without 
notifying the doctoral student.  Workload concerns and logistical issues such as these scenarios 
contributed to the organization’s decision not to administer the MDASI during and after 
medication regimen changes.   
Limitations 
High attrition rates are a common occurrence when observing the palliative care 
population (Visser, Hadley, & Wee, 2015).  Losing patients to follow up may be inherent of 
palliative care research but it is a limitation nonetheless.  Improvements in MDASI scores at 1 
week and 1 month can be noted compared to baseline.  However, very little can be drawn 
regarding the program’s effectiveness with a small sample size. 
Limitations are also noted in the qualitative analysis.  Question 1 of the questionnaire 
asks, “How long have your symptoms affected your life?”  This question was intended to 
determine the amount of time a patient was appropriate for a palliative care referral prior to 
obtaining services.  However, Question 1 of the questionnaire does not answer this intended 
question accurately.  In fact, it is uncertain what can be deduced from this question.  The 
question does not indicate how long symptoms have been poorly controlled, how long symptoms 
have interfered with daily activities, or the amount of time distressing symptoms has 
compromised quality of life. 
The fourth question of the perceived barriers qualitative analysis was another limitation 
of the scholarly project.  The final question asked the patient, “Do you believe where you live 
impacted your ability to receive palliative care.”  First, a significant weakness of this question is 
the close-ended format.  A question that can be answered with a yes or a no does not provide 
means for an in depth qualitative analysis. Additionally, not a single patient believed location of 
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residence impacted the ability to access palliative care.  This response did little to improve the 
understanding of barriers to palliative care services. 
Clinical Implications 
 While the MDASI was moderately accepted by the organization facts for consideration 
are as follows.  A difficulty faced during implementation was building a rapport quickly over the 
phone to make patients confortable and willing to engage with the inventory and questionnaire.  
Although the doctors in the organization were resistant, the MDASI may be better received if the 
physician administered the first inventory face-to-face during the consultation.  When 
determining who would administer the MDASI, the organization discussed the possibility of the 
Social Worker to decrease the workload of the Registered Nurse.  Upon further consideration, 
the organization determined the clinical expertise of the Registered Nurse would improve the 
symptom assessment process.  The frequency of MDASI administration was another topic of 
discussion.  Midway through the implementation process the organization was considering 
administering the MDASI at consultation and at 1 month.  The doctoral student encouraged the 
organization to consider administering the symptom assessment tool at 1 week as well.  It was 
believed that the MDASI contributed to the assessment of medication regimen effectiveness and 
provided valuable follow-up information.  It was also believed that administering the MDASI at 
1 week standardized patient follow-up and guided medication regimen changes.  Administering 
the MDASI during every patient follow up is supported by literature (Ripamonti et al., 2012).  
However, the organization did not believe administering the MDASI prior to medication regimen 
changes and following medication regimen changes was feasible or sustainable.  Following 
discussions the organization decided to administer the MDASI at consultation, 1 week after 
consultation, and 1 month after consultation. 
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Dissemination of Outcomes 
The doctoral student disseminated outcomes by presenting project results to the midwest 
palliative care team.  The presentation focused on referral patient characteristics, the program’s 
performance of managing symptoms, and information learned regarding palliative care barriers 
in rural and non-rural populations.  
Conclusion 
 Palliative care services are provided in an assortment of settings including hospitals, 
outpatient clinics, rehabilitation facilities, assisted living facilities, over the phone, and inside 
patient’s homes (Meyers et al., 2014). Community-based palliative care is a comprehensive and 
multidisciplinary service that follows patients across the disease trajectory though transitions of 
care and a variety of healthcare settings (Kamal et al., 2013).  A significant component of 
palliative care and its success on patient outcomes is the ability of the team to manage distressing 
symptoms (Hui et al., 2014).  Unpleasant symptoms impact almost every facet of a patient’s life 
and impairs functional capacity and increases patient’s distress (Carlson et al., 2012; Cleeland et 
al., 2000).  In order to provide high quality care symptoms must be measured regularly and 
accurately (Cleeland et al., 2000).  A proper symptom inventory will identify symptoms, expose 
severity, and will be sensitive to detect responses from treatment (Cleeland et al., 2000).  
Although no symptom inventory is perfect, the MDASI was deemed sustainable, feasible, and 
was accepted by a midwest palliative care team to assess patient’s symptoms and to provide 
quality measures.    
 
 
 
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 73	
References Adler,	E.	D.,	Goldfinger,	J.	Z.,	Kalman,	J.,	Park,	M.	E.,	&	Meier,	D.	E.	(2009).	Palliative	care	in	the	treatment	of	advanced	heart	failure.	Circulation,	120(25),	2597–2606.	https://doi.org/10.1161/CIRCULATIONAHA.109.869123	American	Association	of	Colleges	of	Nursing.	(2006).	The	essentials	of	doctoral	education	for	advanced	nursing	practice.	Retrieved	from	http://www.aacn.nche.edu/dnp/Essentials.pdf	Armenakis,	A.	A.,	&	Bedeian,	A.	G.	(1999).	Organizational	change:	A	review	of	theory	and	research	in	the	1990s.	Journal	of	Management,	25(3),	293–315.	https://doi.org/10.1177/014920639902500303	Bakitas,	M.	A.,	Elk,	R.,	Astin,	M.,	Ceronsky,	L.,	Clifford,	K.	N.,	Dionne-Odom,	J.	N.,	…	Smith,	T.	(2015).	Systematic	review	of	palliative	care	in	the	rural	setting.	Cancer	Control:	
Journal	of	the	Moffitt	Cancer	Center,	22(4),	450–464.	Bakitas,	M.,	Lyons,	K.	D.,	Hegel,	M.	T.,	Balan,	S.,	Brokaw,	F.	C.,	Seville,	J.,	…	Ahles,	T.	A.	(2009).	Effects	of	a	Palliative	Care	Intervention	on	Clinical	Outcomes	in	Patients	With	Advanced	Cancer:	The	Project	ENABLE	II	Randomized	Controlled	Trial.	JAMA,	
302(7),	741–749.	https://doi.org/10.1001/jama.2009.1198	Befort,	C.	A.,	Nazir,	N.,	&	Perri,	M.	G.	(2012).	Prevalence	of	obesity	among	adults	from	rural	and	urban	areas	of	the	United	States:	Findings	from	NHANES.	The	Journal	of	Rural	
Health,	28(4),	392–397.	https://doi.org/10.1111/j.1748-0361.2012.00411.x	Bekelman,	D.	B.,	Havranek,	E.	P.,	Becker,	D.	M.,	Kutner,	J.	S.,	Peterson,	P.	N.,	Wittstein,	I.	S.,	…	Dy,	S.	M.	(2007).	Symptoms,	depression,	and	quality	of	life	in	patients	with	heart	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 74	
failure.	Journal	of	Cardiac	Failure,	13(8),	643–648.	https://doi.org/10.1016/j.cardfail.2007.05.005	Berwick,	D.	M.,	Nolan,	T.	W.,	&	Whittington,	J.	(2008).	The	triple	aim:	Care,	health,	and	cost.	
Health	Affairs,	27(3),	759–769.	https://doi.org/10.1377/hlthaff.27.3.759	Bharadwaj,	P.,	Helfen,	K.	M.,	Deleon,	L.	J.,	Thompson,	D.	M.,	Ward,	J.	R.,	Patterson,	J.,	…	Bleznak,	A.	D.	(2016).	Making	the	case	for	palliative	care	at	the	system	level:	Outcomes	data.	Journal	of	Palliative	Medicine,	19(3),	255–258.	https://doi.org/10.1089/jpm.2015.0234	Blackhall,	L.	J.,	Read,	P.,	Stukenborg,	G.,	Dillon,	P.,	Barclay,	J.,	Romano,	A.,	&	Harrison,	J.	(2016).	CARE	track	for	advanced	cancer:	Impact	and	timing	of	an	outpatient	palliative	care	clinic.	Journal	of	Palliative	Medicine,	19(1),	57–63.	https://doi.org/10.1089/jpm.2015.0272	Brumley,	R.,	Enguidanos,	S.,	Jamison,	P.,	Seitz,	R.,	Morgenstern,	N.,	Saito,	S.,	…	Gonzalez,	J.	(2007).	Increased	satisfaction	with	care	and	lower	costs:	Results	of	a	randomized	trial	of	in-home	palliative	care.	Journal	of	the	American	Geriatrics	Society,	55(7),	993–1000.	https://doi.org/10.1111/j.1532-5415.2007.01234.x	Burke,	W.	W.,	&	Litwin,	G.	H.	(1992).	A	causal	model	of	organizational	performance	and	change.	Journal	of	Management,	18(3),	523–545.	https://doi.org/10.1177/014920639201800306	Carlson,	L.	E.,	Waller,	A.,	&	Mitchell,	A.	J.	(2012).	Screening	for	distress	and	unmet	needs	in	patients	with	cancer:	Review	and	recommendations.	Journal	of	Clinical	Oncology,	
30(11),	1160–1177.	https://doi.org/10.1200/JCO.2011.39.5509	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 75	
Cashion,	A.	K.,	&	Grady,	P.	A.	(2015).	The	National	Institutes	of	Health/National	Institutes	of	Nursing	Research	intramural	research	program	and	the	development	of	the	National	Institutes	of	Health	Symptom	Science	Model.	Nursing	Outlook,	63(4),	484–487.	https://doi.org/10.1016/j.outlook.2015.03.001	Ceronsky,	L.,	Shearer,	J.,	Weng,	K.,	Hopkins,	M.,	&	McKinley,	D.	(2013).	Minnesota	Rural	Palliative	Care	Initiative:	Building	palliative	care	capacity	in	rural	Minnesota.	Journal	
of	Palliative	Medicine,	16(3),	310–313.	https://doi.org/10.1089/jpm.2012.0324	Chang,	J.	(2000).	Chemotherapy	dose	reduction	and	delay	in	clinical	practice.	Evaluating	the	risk	to	patient	outcome	in	adjuvant	chemotherapy	for	breast	cancer.	European	
Journal	of	Cancer,	36	Suppl	1,	S11-14.	Chang,	V.	T.,	Hwang,	S.	S.,	Feuerman,	M.,	&	Kasimis,	B.	S.	(2000).	Symptom	and	quality	of	life	survey	of	medical	oncology	patients	at	a	Veterans	Affairs	medical	center.	Cancer,	
88(5),	1175–1183.	https://doi.org/10.1002/(SICI)1097-0142(20000301)88:5<1175::AID-CNCR30>3.0.CO;2-N	Chen,	C.	Y.,	Thorsteinsdottir,	B.,	Cha,	S.	S.,	Hanson,	G.	J.,	Peterson,	S.	M.,	Rahman,	P.	A.,	…	Takahashi,	P.	Y.	(2015).	Health	care	outcomes	and	advance	care	planning	in	older	adults	who	receive	home-based	palliative	care:	A	pilot	cohort	study.	Journal	of	
Palliative	Medicine,	18(1),	38–44.	https://doi.org/10.1089/jpm.2014.0150	Chou,	R.,	Fanciullo,	G.	J.,	Fine,	P.	G.,	Adler,	J.	A.,	Ballantyne,	J.	C.,	Davies,	P.,	…	Miaskowski,	C.	(2009).	Clinical	Guidelines	for	the	Use	of	Chronic	Opioid	Therapy	in	Chronic	Noncancer	Pain.	The	Journal	of	Pain :	Official	Journal	of	the	American	Pain	Society,	
10(2),	113–130.	https://doi.org/10.1016/j.jpain.2008.10.008	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 76	
Cleeland,	C.	S.,	Mendoza,	T.	R.,	Wang,	X.	S.,	Chou,	C.,	Harle,	M.	T.,	Morrissey,	M.,	&	Engstrom,	M.	C.	(2000).	Assessing	symptom	distress	in	cancer	patients:	the	M.D.	Anderson	Symptom	Inventory.	Cancer,	89(7),	1634–1646.	Corwin,	E.	J.,	Berg,	J.	A.,	Armstrong,	T.	S.,	Dabbs,	A.	D.,	Lee,	K.	A.,	Meek,	P.,	&	Redeker,	N.	(2014).	Envisioning	the	future	in	symptom	science.	Nursing	Outlook,	62(5),	346–351.	https://doi.org/10.1016/j.outlook.2014.06.006	Dodd,	M.,	Janson,	S.,	Facione,	N.,	Faucett,	J.,	Froelicher,	E.	S.,	Humphreys,	J.,	…	Taylor,	D.	(2001).	Advancing	the	science	of	symptom	management.	Journal	of	Advanced	
Nursing,	33(5),	668–676.	https://doi.org/10.1046/j.1365-2648.2001.01697.x	Dowell	D,	Haegerich	TM,	&	Chou	R.	(2016).	CDC	guideline	for	prescribing	opioids	for	chronic	pain.	JAMA,	315(15),	1624–1645.	https://doi.org/10.1001/jama.2016.1464	Dy,	S.	M.,	Kiley,	K.	B.,	Ast,	K.,	Lupu,	D.,	Norton,	S.	A.,	McMillan,	S.	C.,	…	Casarett,	D.	J.	(2015).	Measuring	what	matters:	Top-ranked	quality	indicators	for	hospice	and	palliative	care	from	the	American	Academy	of	Hospice	and	Palliative	Medicine	and	Hospice	and	Palliative	Nurses	Association.	Journal	of	Pain	and	Symptom	Management,	49(4),	773–781.	https://doi.org/10.1016/j.jpainsymman.2015.01.012	Fan,	G.,	Filipczak,	L.,	&	Chow,	E.	(2007).	Symptom	clusters	in	cancer	patients:	A	review	of	the	literature.	Current	Oncology,	14(5),	173–179.	Follwell,	M.,	Burman,	D.,	Le,	L.	W.,	Wakimoto,	K.,	Seccareccia,	D.,	Bryson,	J.,	…	Zimmermann,	C.	(2009).	Phase	II	study	of	an	outpatient	palliative	care	intervention	in	patients	with	metastatic	cancer.	Journal	of	Clinical	Oncology:	Official	Journal	of	the	American	
Society	of	Clinical	Oncology,	27(2),	206–213.	https://doi.org/10.1200/JCO.2008.17.7568	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 77	
Glasgow,	N.	(2000).	Rural/urban	patterns	of	aging	and	caregiving	in	the	United	States.	
Journal	of	Family	Issues,	21(5),	611–631.	https://doi.org/10.1177/019251300021005005	Gleick,	J.	(1988).	Chaos:	Making	a	new	science.	Penguin.	Go,	A.	S.,	Mozaffarian,	D.,	Roger,	V.	L.,	Benjamin,	E.	J.,	Berry,	J.	D.,	Blaha,	M.	J.,	…	American	Heart	Association	Statistics	Committee	and	Stroke	Statistics	Subcommittee.	(2014).	Heart	disease	and	stroke	statistics--2014	update:	A	report	from	the	American	Heart	Association.	Circulation,	129(3),	e28–e292.	https://doi.org/10.1161/01.cir.0000441139.02102.80	Hearn,	J.,	&	Higginson,	I.	J.	(1999).	Development	and	validation	of	a	core	outcome	measure	for	palliative	care:	The	palliative	care	outcome	scale.	Palliative	Care	Core	Audit	Project	Advisory	Group.	Quality	in	Health	Care,	8(4),	219–227.	https://doi.org/10.1136/qshc.8.4.219	Henly,	S.	J.	(2015).	The	symptom	science	model:	Challenges	in	dissemination	across	the	investigative	sequence.	Nursing	Research,	64(5),	329–330.	https://doi.org/10.1097/NNR.0000000000000119	Higgins,	P.	C.,	Garrido,	M.	M.,	&	Prigerson,	H.	G.	(2015).	Factors	predicting	bereaved	caregiver	perception	of	quality	of	care	in	the	final	week	of	life:	Implications	for	health	care	providers.	Journal	of	Palliative	Medicine,	18(10),	849–857.	https://doi.org/10.1089/jpm.2015.29001.hp	Hughes,	P.	M.,	Ingłeton,	M.	C.,	Noble,	B.,	&	Clark,	D.	(2004).	Providing	cancer	and	palliative	care	in	rural	areas:	A	review	of	patient	and	carer	needs.	Journal	of	Palliative	Care,	
20(1),	44–49.	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 78	
Hui,	D.,	Kim,	S.	H.,	Roquemore,	J.,	Dev,	R.,	Chisholm,	G.,	&	Bruera,	E.	(2014).	Impact	of	timing	and	setting	of	palliative	care	referral	on	quality	of	end-of-life	care	in	cancer	patients.	
Cancer,	120(11),	1743–1749.	Kamal,	A.	H.,	Currow,	D.	C.,	Ritchie,	C.	S.,	Bull,	J.,	&	Abernethy,	A.	P.	(2013).	Community-based	palliative	care:	The	natural	evolution	for	palliative	care	delivery	in	the	U.S.	
Journal	of	Pain	and	Symptom	Management,	46(2),	254–264.	https://doi.org/10.1016/j.jpainsymman.2012.07.018	Kerr,	C.	W.,	Donohue,	K.	A.,	Tangeman,	J.	C.,	Serehali,	A.	M.,	Knodel,	S.	M.,	Grant,	P.	C.,	…	Marien,	M.	J.	(2014).	Cost	savings	and	enhanced	hospice	enrollment	with	a	home-based	palliative	care	program	implemented	as	a	hospice-private	payer	partnership.	
Journal	of	Palliative	Medicine,	17(12),	1328–1335.	https://doi.org/10.1089/jpm.2014.0184	Kerr,	C.	W.,	Tangeman,	J.	C.,	Rudra,	C.	B.,	Grant,	P.	C.,	Luczkiewicz,	D.	L.,	Mylotte,	K.	M.,	…	Serehali,	A.	M.	(2014).	Clinical	impact	of	a	home-based	palliative	care	program:	A	hospice-private	payer	partnership.	Journal	of	Pain	and	Symptom	Management,	48(5),	883–892.	https://doi.org/10.1016/j.jpainsymman.2014.02.003	Kripalani,	S.,	Theobald,	C.	N.,	Anctil,	B.,	&	Vasilevskis,	E.	E.	(2014).	Reducing	hospital	readmission	rates:	Current	strategies	and	future	directions.	Annual	Review	of	
Medicine,	65,	471–485.	https://doi.org/10.1146/annurev-med-022613-090415	Lynn,	J.	(2001).	Serving	patients	who	may	die	soon	and	their	families:	The	role	of	hospice	and	other	services.	Journal	of	America	Medical	Association,	285(7),	925–932.	https://doi.org/10.1001/jama.285.7.925	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 79	
Maltoni,	M.,	Scarpi,	E.,	Dall’Agata,	M.,	Schiavon,	S.,	Biasini,	C.,	Codecà,	C.,	…	Montanari,	L.	(2016).	Systematic	versus	on-demand	early	palliative	care:	A	randomised	clinical	trial	assessing	quality	of	care	and	treatment	aggressiveness	near	the	end	of	life.	
European	Journal	of	Cancer,	69,	110–118.	https://doi.org/10.1016/j.ejca.2016.10.004	Meyers,	K.,	Kerr,	K.,	&	Cassel,	B.	(2014,	September).	Up	close:	A	field	guide	to	community-based	palliative	care	in	California.	Retrieved	January	11,	2017,	from	http://www.chcf.org/publications/2014/09/up-close-field-guide-palliative	National	Cancer	Institute.	(2016,	March	14).	Cancer	Statistics.	Retrieved	February	7,	2017,	from	https://www.cancer.gov/about-cancer/understanding/statistics	Olson,	C.	A.	(2014).	Survey	burden,	response	rates,	and	the	tragedy	of	the	commons.	The	
Journal	of	Continuing	Education	in	the	Health	Professions,	34(2),	93–95.	https://doi.org/10.1002/chp.21238	Paice,	J.	A.	(2004).	Assessment	of	symptom	clusters	in	people	with	cancer.	Journal	of	the	
National	Cancer	Institute.	Monographs,	(32),	98–102.	https://doi.org/10.1093/jncimonographs/lgh009	Paiva,	C.	E.,	Barroso,	E.	M.,	Carneseca,	E.	C.,	de	Pádua	Souza,	C.,	dos	Santos,	F.	T.,	Mendoza	López,	R.	V.,	&	Ribeiro	Paiva,	S.	B.	(2014).	A	critical	analysis	of	test-retest	reliability	in	instrument	validation	studies	of	cancer	patients	under	palliative	care:	a	systematic	review.	BMC	Medical	Research	Methodology,	14,	8.	https://doi.org/10.1186/1471-2288-14-8	Peterson,	S.	J.,	&	Bredow,	T.	S.	(2009).	Middle	range	theories:	Application	to	nursing	
research.	Lippincott	Williams	&	Wilkins.	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 80	
Riley,	G.	F.,	&	Lubitz,	J.	D.	(2010).	Long-term	trends	in	Medicare	payments	in	the	last	year	of	life.	Health	Services	Research,	45(2),	565–576.	https://doi.org/10.1111/j.1475-6773.2010.01082.x	Ripamonti,	C.	I.,	Santini,	D.,	Maranzano,	E.,	Berti,	M.,	&	Roila,	F.	(2012).	Management	of	cancer	pain:	ESMO	clinical	practice	guidelines.	Annals	of	Oncology,	23(7),	139–154.	https://doi.org/10.1093/annonc/mds233	Rummans,	T.	A.,	Clark,	M.	M.,	Sloan,	J.	A.,	Frost,	M.	H.,	Bostwick,	J.	M.,	Atherton,	P.	J.,	…	Hanson,	J.	(2006).	Impacting	quality	of	life	for	patients	with	advanced	cancer	with	a	structured	multidisciplinary	intervention:	A	randomized	controlled	trial.	Journal	of	
Clinical	Oncology:	Official	Journal	of	the	American	Society	of	Clinical	Oncology,	24(4),	635–642.	https://doi.org/10.1200/JCO.2006.06.209	Rycroft-Malone,	J.	(2004).	The	PARIHS	framework:	A	framework	for	guiding	the	implementation	of	evidence-based	practice.	Journal	of	Nursing	Care	Quality,	19(4),	297–304.	US	Census	Bureau.	(2015).	2010	Census	Urban	and	Rural	Classification	and	Urban	Area	Criteria.	Retrieved	April	13,	2017,	from	https://www.census.gov/geo/reference/ua/urban-rural-2010.html	Visser,	C.,	Hadley,	G.,	&	Wee,	B.	(2015).	Reality	of	evidence-based	practice	in	palliative	care.	
Cancer	Biology	&	Medicine,	12(3),	193–200.	https://doi.org/10.7497/j.issn.2095-3941.2015.0041	Walsh,	T.	D.,	Caraceni,	A.	T.,	Fainsinger,	R.,	Foley,	K.	M.,	Glare,	P.,	Goh,	C.,	…	Radbruch,	L.	(2008).	Palliative	medicine.	Elsevier	Health	Sciences.	
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 81	
Xiao,	C.	(2010).	The	state	of	science	in	the	study	of	cancer	symptom	clusters.	European	
Journal	of	Oncology	Nursing,	14(5),	417–434.	https://doi.org/10.1016/j.ejon.2010.05.011	
 
 
 
 
 
 
 
 
 
Appendix A: Theory of Unpleasant Symptoms 
Theory of Unpleasant Symptoms 
ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS	 82	
 
Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The middle-range theory 
of unpleasant symptoms: an update. ANS. Advances in Nursing Science, 19(3), 14–27. 	
Used with permission. See Appendix B. 
 
 
 
 
 
 
Appendix B: Theory of Unpleasant Symptoms Permission 
 
 
Dear Daniel, 
Your project sounds very interesting. If you plan to reproduce the figure in your project report, 
that is acceptable. If you were to use it in something you would sell, then you would need 
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permission from Springer Publishing Company. The publisher company holds the copyright; 
Linda and I do not.  
Good luck with your project.  
Sincerely, 
Elizabeth Lenz, PhD, RN 
Professor Emeritus  
The Ohio State University  
 
Sent from my iPhone 
 
 
On Mar 16, 2017, at 3:18 PM, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote: 
 
Dr. Lenz and Dr. Pugh, 
 
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand 
Rapids, Michigan.  I am emailing you to get permission to use your Theory of Unpleasant 
Symptoms for my scholarly project.  My project is entitled, "Acceptability of the MD Anderson 
Symptom Inventory and qualitative analysis of barriers to palliative care services for rural and 
non-rural populations.”  For this project I am implementing the MD Anderson Symptom 
Inventory in a palliative care program to create quality measures for the organization.  I am also 
conducting a qualitative analysis of patient perceived barriers to accessing palliative care 
services.  I would like permission to use the Theory of Unpleasant Symptoms as my theoretic 
framework.  The project will be uploaded into ScholarWorks upon completion.  Thank you for 
your attention and your time! 
 
 
Daniel Johnson 
DNP Student 
 
 
 
 
 
 
 
 
Appendix C: Burke-Litwin Model of Organizational Performance and Change 
Burke-Litwin Model of Organizational Performance and Change 
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Burke, W. W., & Litwin, G. H. (1992). A causal model of organizational performance and 
change. Journal of Management, 18(3), 523–545. 	
Used with permission. See Appendix D 
Appendix D: Burke-Litwin Model Permission 
 
Dear Mr. Johnson, 
  You have my permission to use the Burke-Litwin Model as a framework for your 
organizational assessment. 
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Good luck with the project. 
W. Warner Burke 
 
On Thu, Mar 16, 2017 at 3:34 PM, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote: 
Dr. Burke, 
 
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand 
Rapids, Michigan.  I am emailing you to get permission to use the Burke-Litwin Model of 
Organizational Change for my scholarly project.  My project is entitled, "Acceptability of the 
MD Anderson Symptom Inventory and qualitative analysis of barriers to palliative care services 
for rural and non-rural populations.”  For this project I am implementing the MD Anderson 
Symptom Inventory in a palliative care program to create quality measures for the 
organization.  I am also conducting a qualitative analysis of patient perceived barriers to 
accessing palliative care services.  I would like permission to use the Burke-Litwin Model of 
Organizational Change as the framework to conduct an organizational assessment.  The project 
will be uploaded into ScholarWorks upon completion.  Thank you for your attention and your 
time! 
 
 
Daniel Johnson 
DNP Student 
 
 
 
--  
W. Warner Burke, PhD 
Edward Lee Thorndike Professor of Psychology and Education 
Editor, Journal of Applied Behavioral Science 
Box 24 Teachers College, Columbia University 
525 West 120th Street 
New York, NY 10027 
(212) 678-3831 
 
 
 
Appendix E: PARiHS Implementation Model Permission 
 
Hello Daniel 
Great to hear you are using PARIHS. 
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As the framework is published - as long as you reference it appropriately that's fine. If you want 
to reproduce one of the figures- depending on which one it is, you will have to seek agreement 
from the publisher. 
 
Regards 
Jo 
 
 
Jo Rycroft-Malone 
Pro-Vice Chancellor, Research & Impact 
Professor of Implementation & Health Services Research 
Bangor University 
 
 
On 16 Mar 2017, at 19:26, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote: 
Dr. Rycroft-Malone, 
 
 
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand 
Rapids, Michigan.  I am emailing you to get permission to use the PARIHS framework for my 
scholarly project.  My project is entitled, "Acceptability of the MD Anderson Symptom 
Inventory and qualitative analysis of barriers to palliative care services for rural and non-rural 
populations.”  For this project I am implementing the MD Anderson Symptom Inventory in a 
palliative care program to create quality measures for the organization.  I am also conducting a 
qualitative analysis of patient perceived barriers to accessing palliative care services.  I would 
like permission to use the PARIHS framework as my implementation model.  The project will be 
uploaded into ScholarWorks upon completion.  Thank you for your attention and your time! 
 
 
Daniel Johnson 
DNP Student 
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Used with permission. See Appendix G 
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Appendix G: MD Anderson Symptom Inventory Permission 
From: symptomresearch 
Sent: Thursday, February 16, 2017 7:01 PM 
To: 'Daniel Johnson'; symptomresearch 
Subject: RE: Order Form for Department of Symptom Research Assessment Tools 
 
Hello, 
I have attached the MDASI as you requested. Please note that: 
• Your use of the MDASI is limited only to the study specified. To use the MDASI in 
additional studies, you must reapply online at  www.mdanderson.org/departments/prg > 
Symptom Assessment Tools > The M. D. Anderson Symptom Inventory (MDASI). 
• You are permitted to reproduce the copy of the MDASI that is included with this e-mail. 
However, you must not remove the copyright notice. 
• The MDASI may not be modified in any way or translated into another language without 
the express written consent of the copyright holder; Charles S. Cleeland, PhD. Failure to comply 
may result in legal action. Permission to alter or translate the instrument may be obtained by 
contacting me at symptomresearch@mdanderson.org or by mail. 
  
Please let me know if you have any questions. Thank you for your interest in the MDASI.  
 
Regards, 
Kristin VanHouten 
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Appendix H: Patient Perceived Barriers Qualitative Analysis 
Date________________ 
County____________ 
Patient Perceived Barriers to Palliative Care Services 
 
1) How long have your symptoms affected your life? 
 
 
 
 
2) What has kept you from receiving palliative care before now? 
 
 
 
 
 
3) How did you learn about palliative care and what they do?  
 
 
 
 
 
4) Do you believe where you live impacted your ability to receive palliative care?  	
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Appendix I: Implementation Staff Survey 
Date_________ 
Professional’s years of hospice and palliative care experience_______ 
 MD Anderson Symptom Inventory (MDASI) Implementation Questionnaire 
 
1) The MDASI provided helpful information at the right time. 
  1        2      3   4  
Strongly Disagree Disagree Agree  Strongly Agree 
 
2) The MDASI contributed to the assessment of patient symptoms 
  1        2      3   4  
Strongly Disagree Disagree Agree  Strongly Agree 
 
3) The MDASI was effective in evaluating medication regimen effectiveness/patient condition 
  1        2      3   4  
Strongly Disagree Disagree Agree  Strongly Agree 
 
4) The administration and follow-up intervals of the MDASI were practical and effective for 
quality patient care and monitoring 
  1        2      3   4  
Strongly Disagree Disagree Agree  Strongly Agree 
 
5) The MDASI contributed to my practice as a healthcare professional and should be sustained 
  1        2      3   4  
Strongly Disagree Disagree Agree  Strongly Agree 
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Appendix J: County of Residence of Palliative Care Program Referrals 
County of Residence of Qualitative Analysis Respondents 
 
 
 
 
 
Patients by County
'
SUM of count by counties
Allegan
2
Kent
4
Ottawa
18
VanBuren
1
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Appendix K: Boxplot of Patient Reported Pain at Consultation 
Boxplot of Pain at Consultation 
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Boxplot of Pain at Intial Interaction
'
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Appendix L: Table of Patient Reported Pain at Consultation 
Patient Reported Pain at Consult 
N Mean 
Standard 
Deviation Minimum 
Lower 
Quartile Median 
Upper 
Quartile Maximum 
15 7.93 2.05 4.00 6.00 9.00 10.00 10.00 
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Appendix M: Pain Improvement Measured with MDASI 
Improvement of Pain Scores at One-Week Compared to Pain at Consultation 
N 
Mean Pain 
Score 
Improvement 
Standard 
Deviation 
Minimum 
Improvement 
Lower 
Quartile Median 
Upper 
Quartile Maximum 
7 6.00 2.52 2.00 3.00 7.00 8.00 8.00 
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Appendix N: Fatigue, Nausea, Distress, and Interference of Enjoyment of Life Scores at 
Consultation 
Fatigue, Nausea, Distress, and Interference of Enjoyment of Life Scores at Consultation 
Variable N 
Mean 
Score 
Standard 
Deviation Minimum 
Lower 
Quartile Median 
Upper 
Quartile Maximum 
Fatigue 19 6.74 2.10 3.00 5.00 7.00 8.00 10.00 
Nausea 19 2.47 2.99 0.00 0.00 1.00 4.00 10.00 
Distress 19 5.47 3.12 1.00 2.00 6.00 8.00 10.00 
Enjoyment 
of Life 
Interference 
19 6.84 3.10 0.00 5.00 7.00 10.00 10.00 
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Appendix O: Improvement of MDASI Scores at 1-Week Compared to Consultation 
Improvement of MDASI Scores at 1-Week Compared to Consultation  
Variable N Mean 
Standard 
Deviation Minimum 
Lower 
Quartile Median 
Upper 
Quartile Maximum 
Pain 6 2.67 1.97 1.00 1.00 2.00 4.00 6.00 
Fatigue 6 1.17 4.17 -4.00 -2.00 0.50 5.00 7.00 
Nausea 6 1.00 5.37 -6.00 -2.00 0.50 3.00 10.00 
Disturbed 
Sleep 
6 0.83 5.31 -5.00 -5.00 1.00 6.00 7.00 
Distress 6 0.50 5.36 -5.00 -5.00 0.50 3.00 9.00 
Enjoyment 
of Life 
Interference 
6 0.67 3.88 -5.00 -2.00 1.00 3.00 6.00 
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Appendix P: Improvement of MDASI Scores at 1-Month Compared to Consultation 
Improvement of MDASI Scores at 1-Month Compared to Consultation 
Variable N Mean 
Standard 
Deviation Minimum 
Lower 
Quartile Median 
Upper 
Quartile Maximum 
Pain 6 3.50 1.22 2.00 3.00 3.00 5.00 5.00 
Fatigue 6 1.67 1.51 0.00 1.00 1.00 3.00 4.00 
Nausea 6 0.83 2.56 -1.00 -1.00 -0.50 3.00 5.00 
Disturbed 
Sleep 
6 3.00 4.00 0.00 0.00 1.00 7.00 9.00 
Distress 6 0.83 5.88 -6.00 -4.00 0.00 6.00 9.00 
Enjoyment 
of Life 
Interference 
6 2.00 2.76 -1.00 0.00 1.50 4.00 6.00 
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Appendix Q: Frequency of MDASI Administration for Patients Referred Prior to March 16 
Frequency of MDASI Administration for Patients Referred Prior to March 16 
Number of 
Administrations 
Number 
of Patients 
1 10 
2 8 
3 6 
4 4 
5 1 
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Appendix R: Time to Administer MDASI 
Time to Administer MDASI in Minutes 
N Mean 
Standard 
Deviation Minimum 
First 
Quartile Median 
First 
Quartile Maximum 
38 6:27 2:20 3:01 4:32 5:55 8:22 11:25 
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Appendix S: Implementation Staff Survey Responses 
Means and Standard Deviations of Staff Responses to Implementation Survey 
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Appendix T: IRB Approval 
 
DATE: February 13, 2017 
TO: Daniel Johnson, BS, BSN 
FROM: Grand Valley State University Human Research Review Committee 
STUDY TITLE: [1028150-2] Acceptability of the MD Anderson Symptom Inventory 
and 
qualitative analysis of barriers to palliative care services for rural and non- 
rural populations 
REFERENCE #: 17-142-H 
SUBMISSION TYPE: New Project 
ACTION: NOT 
RESEARCH EFFECTIVE DATE:
 February 13, 
2017 
REVIEW TYPE: Administrative Review 
 
Thank you for your submission of materials for your planned research study. It has been determined 
that this project: 
 
Does not meet the definition of covered human subjects research* according to current federal 
regulations. The project, therefore, does not require further review and approval by the HRRC. 
 
Any research-related problem or event resulting in a fatality or hospitalization requires immediate 
notification to the Human Research Review Committee Chair, Dr. Steve Glass, (616)331-8563 
AND Human Research Protections Administrator, Dr. Jeffrey Potteiger, Office of Graduate 
Studies (616)331-7207. See HRRC policy 1020, Unanticipated problems and adverse events. 
Exempt research studies are eligible for audits. 
 
If you have any questions, please contact the Office of Research Integrity and Compliance at (616) 
331-3197 or rci@gvsu.edu. The office observes all university holidays, and does not process 
applications during exam week or between academic terms. Please include your study title and 
reference number in all correspondence with our office. 
 
*Research is a systematic investigation, including research development, testing and 
evaluation, designed to develop or contribute to generalizable knowledge (45 CFR 46.102 (d)). 
 
Human subject means a living individual about whom an investigator (whether professional or student) 
conducting research obtains: data through intervention or interaction with the individual, or identifiable 
private information (45 CFR 46.102 (f)). 
 
Scholarly activities that are not covered under the Code of Federal Regulations should not be 
described or referred to as research in materials to participants, sponsors or in dissemination of 
findings. Research	Protections	Program	|	1	Campus	Drive	|	049	James	H	Zumberge	Hall	|	Allendale,	MI	49401	Ph	616.331.3197	|	rpp@gvsu.edu	|	www.gvsu.edu/rpp	
